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ABBREVIATIONS 
 
1,25(OH)2D3        1,25-Dihydroxycholecalciferol 
BrdU                    Bromodeoxyuridine 
CPPs                    Casein phosphopeptides 
Ca2+                       Free calcium ions 
[Ca2+]i                    Intracellular calcium concentration 
[Ca2+]o                   Extracellular calcium concentration 
CaSR                    Calcium Sensing Receptor 
DiBAC4(3)           Bis-(1,3-dibutylbarbituric acid) trimethine oxonol 
DMEM                 Dulbecco’s modified Eagle’s medium  
DMSO                  Dimethyl sulphoxide 
EDTA                   Ehylenediaminetetraacetic acid 
EGTA                   Ethyleneglycol-bis-(2-aminoethyleter)N,N,N’,N’-tetraacetic acid  
EMEM                  Eagle’s Minimum Essential Medium  
FBS                       Foetal Bovine Serum 
Fura-2/AM           Fura-2 acetoxymethyl ester 
Fura-2                   Fura-2 
KRH  SD              Krebs Ringer Hepes buffer  
KRH MOD          Krebs Ringer Hepes buffer modified 
RPMI 1640           Roswell Park Memorial Institute Medium 
TRPV6                  Transient receptor potential cation channel subfamily V member 6 
VDR                      Nuclear vitamin D receptor  
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CALCIUM HOMEOSTASIS IN THE INTESTINAL CELLS 
Calcium is an essential micronutrient in the human diet and is derived mainly from 
milk and dairy products (78%), while fewer derived from fruits and vegetables (20%), 
and even fewer from meat and fish (5%). The absorption of dietary calcium is 
intrinsically related to the chemical nature of the food source and to the individual 
nutritional, metabolic and physiological status. Even the compounds introduced in 
combination with calcium may affect its absorption, such as phytate, oxalate, phenolic 
compounds, lactose, phosphorus, and of course vitamin D, which plays a decisive role 
in this process. The phytate in cereals and legumes, for example, form insoluble or 
poorly soluble complexes with calcium in alkaline pH, making calcium ions 
unavailable for absorption (Kitts and Yuan 1992), and some pectins drastically inhibit 
the intestinal absorption of calcium and other minerals (Gueguen and Pointillart 2000). 
On the other hand several species of fibers (cellulose, hemicellulose, lignin and non-
cellulosic polysaccharides) do not seem to directly influence the absorption of the ion, 
but different non-digestible carbohydrates and oligosaccharides are able to increase its 
absorption from the distal part of intestines, by increasing the bacterial fermentation 
and lowering the pH of intestinal environment (Gueguen and Pointillart 2000). 
Approximately 99% of calcium in the body is in the form of calcium phosphate, the 
main constituent of bone mineral (Bronner 1988). It follows that the bulk of the 
ingested calcium is accumulated and retained in the skeletal tissue. The rate of 
deposition of calcium in bones is high in the newborn and decreases until the end of 
the development of 'individual, in parallel, the rate of removal of calcium from the 
bones tends to equalize the deposition rate (Bronner and Pansu 1999). The process of 
deposition and removal of calcium from bone is under the control of hormones such as 
parathyroid hormone and calcitonin, which along with vitamin D regulate the 
homeostasis of calcium ions in the body, also intervening in the kidneys and intestines. 
It is widely accepted there are two pathways of absorption: one transcellular, the other 
paracellular. Transcellular Ca2+ absorption is secondary active absorption, requiring 
ATP hydrolysis by the Ca2+ dependent ATPase in the basolateral membrane; it is 
mediated, can occur at luminal Ca2+ concentrations below those in plasma, and is 
stimulated by 1,25(OH)2D3. In contrast, paracellular absorption is passive, being driven 
by high Ca2+ concentrations through tight junctions down transepithelial 
electrochemical gradients; it is often described as vitamin D independent. In these 
conventional terms, active, transcellular absorption is a saturable process occurring at 
luminal concentrations up to approximately 5 mM, whereas paracellular absorption 
displays linear or diffusive kinetics between 5 and 200 mM Ca2+. 
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The relative contribution of transcellular and paracellular components to total Ca2+ 
absorption is a matter of some debate but principally depends on the amount and 
concentration of ionized Ca2+. A current, general view is that the transcellular 
component accounts for approximately 50% in duodenum, decreasing to 20% in 
jejunum and 0% in ileum. However, because the transcellular component depends on 
the Ca2+ content of the diet, such figures are merely guidelines. Thus, at low Ca2+ 
intakes, when the transcellular component is upregulated by 1,25(OH)2D3, paracellular 
flow accounts for perhaps <10% of duodenal absorption. In contrast, at high intakes, 
transcellular absorption is downregulated, so that paracellular flow then accounts for 
>90% of duodenal absorption. Since the absorptive capacity of the duodenum is 
diminished at high intakes, the majority of Ca2+ absorption is said to occur by 
paracellular flow at high concentrations in the jejunum and ileum (Kellett 2011). 
There are two main models of active, transcellular intestinal Ca2+ absorption, regulated 
by genomic or non-genomic pathways (Figure 1). The most widely accepted is the 
facilitated diffusion model; it comprises three steps, involving TRPV6 (CaT1), a 
member of the transient receptor potential vanilloid subfamily, calbindin-D9K, and 
PMCA1b, the predominant form in intestine (Choi and Jeung 2008; Hoenderop, et al. 
2005; Peng, et al. 2003). In the duodenum, apical Ca2+ entry into the enterocytes occurs 
through TRPV6, which is activated by hyperpolarization and is relatively insensitive to 
L-type channel inhibitors (Peng, et al. 1999; Suzuki, et al. 2008). Transport across the 
apical membrane is strongly favored by an electrochemical gradient. Cytosolic 
diffusion of Ca2+ is facilitated 70-fold by binding to calbindin-D9K, which acts as a Ca2+ 
ferry or fire-bucket brigade. Finally, Ca2+ is transported across the basolateral 
membrane against the electrochemical gradient via PMCA1b. About 80% of Ca2+ exits 
via this route, the remaining 20% via the Na+/ Ca2+ exchanger. 
Components of the facilitated diffusion model are strongly upregulated by 
1,25(OH)2D3 through the vitamin D receptor (VDR) or by a low- Ca2+ diet. Conversely, 
both are downregulated by high dietary Ca2+ intake and low 1,25(OH)2D3. PMCA1b is 
also regulated by 1,25(OH)2D3 (Johnson and Kumar 1994). The protein and mRNA 
expression levels of TRPV6, calbindin-D9K, and PMCA1b, as determined by 
immunocytochemistry and quantitative polymerase chain reaction, are highest in 
duodenum and decrease distally; they are also present in cecum and colon 
(Armbrecht, et al. 2003; Hoenderop, et al. 2000; Zhuang, et al. 2002). The vesicular 
transport model for rapid non-genomic regulation is based on work in chick 
duodenum, which expresses calbindin-D28K (Khanal and Nemere 2008b; Larsson, et al. 
1998). Stimulation of Ca2+ entry by vitamin D acting through the 1,25(OH)2D3-MARRS 
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(membrane-associated, rapid response steroid-binding) receptor increases Ca2+ in the 
subapical region within minutes, disrupting actin filaments (Nemere 2005). 
The ensuing endocytotic vesicles are transported by microtubules to fuse with 
lysosomes and, ultimately, with the basolateral membrane to secrete Ca2+ and 
calbindin-D28K into the circulation (Figure 1). Lysosomal/basolateral fusion may 
involve control of local Ca2+ concentrations by influx through basolateral L-type 
channels in conjunction with efflux through PMCA1b, consistent with the observation 
of rapid Ca2+ recycling across the basolateral membrane (Khanal and Nemere 2008a). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Calcium transport in rat jejunum. A central feature is that transcellular absorption is 
regulated by alternative depolarization and repolarization of the apical membrane during and 
between digestive periods, respectively. There are two active transcellular pathways for Ca2+ 
absorption, which have complementary roles: entry to one is mediated by TRPV6, which is 
activated by hyperpolarization of the apical membrane, and entry to the other is mediated by 
Cav1.3, which is activated by depolarization. Entry through TRPV6 controls three potential 
routes: 1) the facilitated diffusion pathway by calbindin-D9K; 2) simple diffusion of free Ca2+; and 
3) the vesicular transport pathway, in which Ca2+  and calbindin-D9K are simultaneously released 
into the plasma by vesicle fusion with the basolateral membrane. TRPV6, calbindin-D9K, and 
PMCA1b are also upregulated genomically by vitamin D. 
Cav1.3 is activated by Na+/glucose co-transport through SGLT1 and by other depolarizing 
nutrients, including amino acids and oligopeptides. The transcellular pathway is not yet 
established but is independent of calbindin-D9K and, probably, vitamin D. Absorption through 
Cav1.3 also regulates apical GLUT2 insertion. Paracellular absorption is shown as a minor 
component, given that Cav1.3, alone or in conjunction with TRPV6, offers alternative 
explanations for some phenomena currently attributed to paracellular flow. Dashed lines: with 
arrowhead, activation; with bar, inhibition (Kellett 2011). 
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A fundamental issue is how intestinal Ca2+ absorption occurs under the depolarizing 
conditions of digestion. The products of the digestion of disaccharides, peptides, and 
amino acids are strongly depolarizing and are generated throughout jejunum and 
ileum, which are the absorptive regions with the longest transit time for food. Two 
possible mechanisms might operate under depolarizing conditions: nutrient-induced 
paracellular flow and/or activation of L-type channels. It is widely accepted that the 
major pathway of Ca2+ absorption attributed to paracellular flow occurs in jejunum and 
ileum, which have a much more depolarizing environment than duodenum after a 
meal. 
Nevertheless, it is also widely accepted that intestinal epithelial cells do not contain L-
type channels, since enterocytes are activated by hyperpolarization (Petersen and 
Fedirko 2001). This view was reinforced by the discovery of ECaCs, which do not 
contain the S4 voltage sensor present in L-type channels and are activated by 
hyperpolarization in the range of -60 to -150 mV (Figure 2). Hence, TRPV6 was found 
to be located largely in the duodenum, which has a relatively polarizing environment 
and a very short chyme transit time. The most widely accepted mechanism of 
transcellular Ca2+ absorption, therefore, does not, indeed cannot, explain the 
fundamental issue of absorption during digestion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Structural organization of TRPV6. A: the epithelial Ca2+ channels are 730 amino acids 
long with a predicted molecular mass of 83 kDa. TRPV6 contain a core domain consisting of 6 
transmembrane (TM) segments. In addition, a large cytosolic amino and carboxy terminus are 
present containing ankyrin repeats. Between TM5 and TM6 there is a short hydrophobic stretch 
predicted to be the pore-forming region of these channels. Inner and outer side of the membrane 
is indicated. B: potential regulatory sites in the amino and carboxy tail of TRPV6 including 
ankyrin repeats and PDZ motifs and conserved PKC phosphorylation sites (Hoenderop et al. 
2005). 
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There is, in fact, clear evidence that L-type channels are present in enterocytes. Of 
particular relevance is the demonstration of L-type channels in the apical membrane of 
Atlantic cod intestine (Larsson et al. 1998). At 10 mM Ca2+, imaging experiments 
revealed that K+-induced depolarization of Fura-2 loaded isolated cells resulted in a 
wave of Ca2+ entering at the apical membrane and exiting at the basolateral membrane 
about 1 minute later (Larsson et al. 1998). The associated increase in intracellular Ca2+ 
levels was mimicked by Bay K 8644 and blocked by nifedipine (5 mM). 
A role for apical Ca2+ entry was confirmed by single-pass perfusion of rat jejunum in 
vivo; entry could not involve TRPV6, which lacks the S4 voltage sensor and is opened 
by hyperpolarization, i.e., between -60 and -150 mV (Hoenderop, et al. 1999; Peng et al. 
1999). Furthermore, TRPV6 is located predominantly in duodenum,(Hoenderop et al. 
2000; Zhuang et al. 2002) which has a relatively polarizing environment, modest 
glucose absorption, and negligible apical GLUT2 insertion. 
The depolarizing conditions in jejunum pointed to an apical L-type channel. 
Transcripts of the non-classical neuroendocrine Cav1.3 α1 pore-forming subunit and 
an associated β3 subunit were amplified from jejunal mucosal cDNA using an 
homology-based polymerase chain reaction approach (Morgan, et al. 2007); no other L-
type channel was detected. Protein expression of both subunits was localized by 
Western blotting and immunocytochemistry to the apical membrane. Ca2+ absorption 
displayed L-type characteristics (Morgan et al. 2007; Morgan, et al. 2003). 
Cav1.3 is a second channel capable of active, transcellular Ca2+ absorption in intestine. 
Cav1.3 is activated by membrane depolarization. Cav1.3 can therefore operate under 
conditions of sustained, weak membrane depolarization at low-voltage thresholds, 
such as those generated by nutrient absorption around -47 mV. 
TRPV6 is strongly activated at Vm values from -60 mV to -150 mV and Cav1.3 at more 
positive potentials from +10 mV to -20 mV. This suggests TRPV6 and Cav1.3 have 
complementary roles in Ca2+ entry. The scenario below assumes that TRPV6 and 
Cav1.3 make independent contributions to absorption (Nakkrasae, et al. 2010). 
In terms of extending the current perspective of Ca2+ absorption, the simplest proposal 
is that rapid changes in Ca2+ absorption during digestion occur as a consequence of 
alternate depolarization and repolarization during and between digestive periods; the 
changes are achieved by alteration in the contributions of Cav1.3 and TRPV6, 
respectively, in response to changes in Vm. In this view, Cav1.3 plays the dominant role 
during digestion, especially when diet and Ca2+ are plentiful, so that TRPV6 activity is 
downregulated genomically and inhibited by changes in Vm when glucose 
concentrations at the apical membrane can reach 30–100 mM (Mace, et al. 2007). Other 
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depolarizing digestion products, such as amino acids and peptides, may activate 
Cav1.3 and inhibit TRPV6.  
Moreover, depolarization is augmented by increased synthesis of disaccharidases and 
nutrient transporters. On the other hand, TRPV6 plays a dominant role as a powerful 
scavenger under the polarizing conditions between meals. 
In a situation in which luminal Ca2+ is less than plasma Ca2+ it is essential that TRPV6 be 
both activated by apical membrane repolarization and up-regulated by vitamin D to 
prevent massive loss of Ca2+ from the body. Perhaps this is the fundamental reason 
why vitamin D and TRPV6 are so important in Ca2+ homeostasis overall. The interplay 
of TRPV6 and Cav1.3 is essential to maintain the exceptionally tight control of free Ca2+ 
concentration in the extracellular space over the entire range of dietary intake, both of 
Ca2+ and other nutrients (Kellett 2011). 
Cav1.3 mediates entry to a second active transcellular pathway in the heart of the 
digestive center, regulated by depolarizing nutrients and hormones. In particular, 
rapid glucose- and prolactin-induced Ca2+ absorptions through Cav1.3 are both 
independent of calbindin-D9K and probably of vitamin D. TRPV6 is activated by 
hyperpolarization; hence, Cav1.3 does what TRPV6 cannot, i.e., operate optimally 
during dietary Ca2+ intake under the depolarizing conditions of digestion. 
A novel, integrated view of transcellular Ca2+ absorption is presented based on the idea 
that Cav1.3 and TRPV6 have independent and complementary actions, being activated 
by depolarization and repolarization during and between digestive periods, 
respectively (Kellett 2011). 
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REGULATORY MECHANISMS OF CALCIUM INSIDE THE CELL 
Calcium, in addition to playing a nutritional role, is also an important second 
messenger and a regulator of cellular functions. It is involved in many cellular 
responses, such as muscle contraction, nerve transmission, secretion, also plays an 
important role in regulating cell growth and differentiation, and apoptosis. 
The concentration of intracellular calcium, [Ca2+]i (0.1-0.2 µM) is four orders of size 
lower than extracellular calcium, [Ca2+]o or (1-2 mM), thus the maintenance of this 
gradient, and the rapid increase in [Ca2+]i (10-20 times in a few milliseconds), observed 
after stimulation with an agonist, are the result of coordinated action of several 
mechanisms that include: influx and efflux of calcium through the cytoplasmic 
membrane, intracellular calcium stores and buffer systems (Figure 3). 
The entry of calcium from the extracellular environment occurs through channels 
present at the plasma membrane; according to the mechanism of activation is possible 
to determine the different types (Kitts and Yuan 1992; Nelson and Cox 2006) 
Channels activated by the presence of an extracellular chemical signal (ligand), which, 
according to their mechanism of action can be further subdivided into:  
 ROCCs (Receptor-Operated Ca2+ Channels): calcium channel regulated by a 
receptor where the ligand binding site and the channel are included in the 
same protein or part of the same complex. These channels open as a result of 
competitive binding to the receptor without the involvement of diffusible 
second messengers.  
 GOCCs (G protein-Operated Ca2+ Channels). channels directly coupled to 
receptors through G protein.  
 SOCCs (Stores-Operated Ca2+ Channels). channels activated by depletion of 
intracellular stores, with a mechanism of activation still uncertain.  
 SMOCCs (Second Messenger-Operated Ca2+ Channels): channels activated by 
a second messenger. The opening of these channels is controlled by a diffusible 
cytosolic messenger whose production is due to ligand-receptor interaction. 
Voltage-activated channels (VOCCs), whose presence was detected in both excitable 
cells, such as nerve and muscle fibers and in no-excitable cells, such as fibroblasts. The 
opening of these channels occurs as a result of depolarization of the plasma membrane. 
The VOCCs can be divided into different classes according to electrophysiological 
characteristics and sensitivity to different inhibitors, making the complexity and 
functional characteristics of these channels in different types of cells. 
In the cell there are several ways of buffering or sequester calcium to prevent an 
uncontrolled increase in [Ca2+]i prolonged. 
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The transport processes located in the plasma membrane are able to guarantee the 
maintenance of an adequate level of cytosolic free calcium ions and consist of two 
main systems for extrusion of the ion, ensuring the maintenance of the concentration 
gradient: the Ca2+-ATPase and Na+/Ca2+ exchanger. The Ca2+-ATPase is an active 
transport system, ubiquitous in eukaryotic cells, which can bind intracellular calcium 
with high affinity and release it in the environment outside the plasma membrane by 
consuming ATP. The Na+/Ca2+ exchanger is present in only a few cell types, especially 
in excitable cells (muscle and nerve), coupling the release of one calcium ion against  
gradient to the entry of three sodium ions into cells following the gradient (Putney 
1999). 
There are other mechanisms which are key in maintaining ion homeostasis, such as the 
binding to cytosolic proteins and the accumulation in intracellular compartments. In 
the cell, as well as in mitochondria and Golgi apparatus, where calcium concentrations 
are extremely high, the main organelle involved in storage and in the rapid exchange 
of calcium after cell stimulation is the endoplasmic reticulum, and, in particular, one 
specialized sub-compartments: the calciosoma. Studies on skeletal muscle (Lamb and 
Stephenson 1992) have shown that the accumulation of calcium in the 
sarco/endoplasmic reticulum occurs against the gradient through the Ca2+-ATPase, 
present in the membrane of this organelle, and capable of transporting two calcium 
ions into the lumen of the reticulum for each molecule of hydrolyzed ATP. 
Within the intracellular stores, most of the calcium is not present in ionic form, but is 
bound to proteins with low affinity (Kd = 1-4 mmol/ L) and high binding capacity (25-
50 calcium moles/mole of protein) toward the ion, which enhance the ability to storage 
of the endoplasmic reticulum (Wasserman and Fullmer 1995): the calsequestrin, 
present mainly in muscle cells, and calreticulin, common in a greater number of cell 
types. The release of calcium from intracellular stores is due to inositol 1,4,5 
triphosphate (IP3): it derives from the cleavage of phosphatidyl-inositol-4 ,5-
bisphosphat by the action of phospholipase C, coupled with a G protein. The IP3 acts 
as a second messenger by binding to its receptor, located at the membrane of the 
endoplasmic reticulum, activates calcium channel response resulting in the release of 
the ion in the cytosol (Berman 1999). This process depends critically on the biphasic 
[Ca2+]i: at low concentrations (<0.3 mM) calcium acts as a co-agonist of IP3 (thus 
exerting a positive control on his release from the endoplasmic reticulum), whereas at 
higher concentrations exerts a negative control on the release of Ca2+-induced by IP3, 
inhibiting the receptor and thus preventing further release of Ca2+ (Orrenius, et al. 
2003).  
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Inside the eukaryotic cell, there are also systems that are able of buffering large 
transient increases in [Ca2+]i that could lead to the activation of enzymatic reactions 
harmful for the cell. These are proteins with an heterogeneous affinity and ability to 
bind Ca2+, which take place inside the cell Ca2+-dependent enzymatic action (for 
example, phosphorylase) or regulatory (eg calmodulin). This last plays an important 
role in the modulation of a variety of physiological processes (such as Ca2+-ATPase 
activity of the membrane), as well as representing the cytoplasmic protein important in 
binding Ca2+, in virtue of its high concentration (approximately 1% of total cellular 
proteins) and the presence in it of four binding sites for Ca2+. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Intracellular Ca2+ homeostasis. The extracellular Ca2+ can enter the cell through voltage-
gated channels permeable to Ca2+ (VOOCs), channels sensitive to the concentration of 
intracellular Ca2+ (SOOCs), channels through G protein-coupled receptors (ROCCs). Ca2+ in the 
endoplasmic reticulum is released into the cytosol through channels opened by IP3. The PLC 
hydrolyzes PIP2, producing IP3 and DAG. The intracellular concentration of calcium is returned 
to baseline by extrusion of the ion mediated by Ca2+-ATPase present on the plasma membrane 
(PMCA) and on the membrane of the endoplasmic reticulum (SERCA), or by the antiport Na+/ 
Ca2+ (Orrenius et al. 2003). 
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MORPHOLOGY OF THE INTESTINAL MUCOSA 
After birth, the intestinal mucosa is constantly subjected to stimuli from the external 
environment and plays a key role in absorption and metabolism of nutrients, drugs 
and other substances in transit through the intestinal lumen. 
Intestine enterocytes are alternating with goblet cells and are based on a layer of 
connective tissue, the lamina propria, thus going to constitute the intestinal mucosa. To 
increase the total absorption area, the mucosa rises in the finger-like formations, the 
intestinal villi, in which enterocytes are arranged in a very specific way (Dalle Donne, 
et al. 2010). 
At the base of the villi, in the formations known as crypts, the cells are functionally 
"stem cells", which are characterized by high self-replicating capacity, which leads 
them to be a clone of cells designed to maintain this proliferative rate. In addition there 
are cells moving away from the crypt reaching the surface of the villi. During this route 
the cells change, no longer proliferate and assume characteristics of differentiated cells 
(de Santa Barbara, et al. 2003) (Figure 4). Differentiated epithelial cells have a well 
developed junctional apparatus, which divides the plasma membrane in a basolateral 
and apical compartment, causing a functional polarity. The junctions most 
representative in the epithelial cells are adherent junctions that, in addition to promote 
adherence and maintain tissue integrity, facilitate intercellular communication (Dejana 
2004). Among the markers of epithelial differentiation, a major role is played by the E-
cadherin, a transmembrane protein present in adherent junctions, which has an 
extracellular portion, a transmembrane domain and cytoplasmic tail. The extracellular 
domain of E-cadherin establishes homophilic calcium-dependent interactions with 
similar molecules of adjacent enterocytes, while its intracellular tail binds to proteins 
such as cytoplasmic β-catenin, which are joined to the cytoskeletal actin filaments 
(Farquhar and Palade 1963). This anchoring allows both the cytoskeleton stabilization 
and the dynamic adjustment of the opening and closing of joints themselves (Dejana 
2004). At the apex of the villus cells, now have reached the final stage differentiation 
and viability, undergo programmed cell death, apoptosis. The balance between the 
high proliferative rate in the crypts and apoptosis at the apex of the villi allows to 
avoid the production of a mass of cells along the axis of the villi, which lead to the 
formation of microadenomas, polyps and carcinomas. 
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Figure 4. Morphological representation of the organization of the small intestine (‚Fondamenti 
di nutrizione umana‛; A.M. Costantini, C. Cannella, G.Tomassi; Il Pensiero Scientifico Editore). 
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CALCIUM AND CARCINOGENESIS 
Colorectal tumors are one of the most common forms of cancer (Jemal, et al. 2005) and 
are the second leading cause of cancer mortality in industrialized societies (Greenwald 
1992). A common feature in the development of this disease is an increased 
proliferative activity of intestinal cells together with the arrest of cell growth control 
(Brown and Attardi 2005) and the loss of a defined morphology (Christiansen and 
Rajasekaran 2006). 
Recent epidemiological studies have shown that the incidence of colon cancers is 
inversely proportional to intake of dietary calcium and to the presence of vitamin D in 
our body in its active form, 1,25(OH)2D3 (Jacobs, et al. 2009; Peterlik, et al. 2009). 
At the level of colon cells, the concentration of calcium needed to maintain a balanced 
proliferative rate is significantly lower than required by cells such as fibroblasts and 
hepatocytes (1.0-1.5 mm versus 0.8-2.2 mM) (Whitfield, et al. 1995). An excess of 
extracellular calcium, such as that due to a meal, which can reach values of 6-8 mM 
(Bronner and Pansu 1999), has as a direct consequence the blockade of proliferation 
and the expression of a differentiated phenotype, characterized by the presence of 
adherent junctions between cells (Whitfield 2009). 
The molecular mechanisms underlying this transformation see the involvement of two 
main mechanisms: the Wnt mechanism and CaSR (Calcium Sensing Receptor). The 
Wnt mechanism, consisting of a series of glycoproteins released by cells of 
mesenchymal stromal crypts, controls cell proliferation through the complex between 
the nuclear β-catenin and the transcription factor 4 (TCF4), a nuclear transcription 
factor that belongs to the family of T cell receptors (Korinek, et al. 1997). This complex 
activates a number of genes required for cell proliferation, including c-myc, and 
cyclinD1, leading to the expression of an anti-apoptotic protein (survivin) and to the 
inhibition of the "cycling p21 cell-stopper", thus allowing cells at the base of the crypts 
to replicate (Chakrabarty, et al. 2005). 
The increase in extracellular calcium concentration activates the entry of these ions into 
the cells through specific channels, including the TRPV6 (Transient Receptor Potential 
vanilloid Calcium channel, even channel CAT1), belonging to the superfamily of 
channels Transient Receptor Potential (TRP) (Peng et al. 1999) and activates the 
expression of the CaSR. The CaSR, a G protein-coupled receptor having as the main 
physiological ligand calcium, is able to "detect" even minimal variations in the 
extracellular concentration of this ion and to "translate" into mechanisms of 
activation/inhibition of cellular functions (Gama, et al. 1997). Physiologically, is 
expressed at the apex of the villi during the differentiation of enterocytes, which are in 
contact with a calcium concentration significantly higher than that found at the bottom 
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of the crypts (Brenner, et al. 1998; Chakrabarty et al. 2005). CaSR invokes calcium ions 
into cells, thus establishing a cycle calcium-CaSR that has as its ultimate effect the 
coordination of the events of proliferation-differentiation-apoptosis. One of the first 
events of the calcium-CaSR cycle is the translocation of β-catenin from the nucleus to 
the cytoplasm, with dissociation of the complex TCF4-β-catenin and the appearance of 
the APC (adenomatous polyposis coli protein) in the cytoplasm. These events induce 
the expression of E-cadherin (Chakrabarty et al. 2005) which promotes the structural 
organization of adherent junctions between adjacent epithelial cells. At this stage, the 
cells acquired a differentiated phenotype, associated with the inhibition of the survivin 
protein, and the further migration at the apex of villus, leads to complete their life 
cycle with apoptosis. All these steps are tightly regulated in healthy cells at the 
genomic and post-genomic level (Clevers 2006; Hoffman, et al. 2004; Pinto and Clevers 
2005) (Figure 5).  
Vitamin D can modulate gene expression in ways specific to each tissue, primarily by 
inhibiting cell proliferation, inducing cell differentiation and apoptosis, processes 
which, in turn, may protect cells from tumor transformation (Chiang and Chen 2009). 
The chemopreventive action of vitamin D, similar to calcium, is expressed through the 
interaction with calcium both activating/inhibiting antiproliferative/pro-differentiating 
ways and promoting the expression of CaSR (Peterlik et al. 2009). 
Enterocytes that undergo a premalignant transformation lose the ability to respond to 
the differentiating stimulus represented by a high concentration of extracellular 
calcium. In addition, clones of cells appears quite unable to express the CaSR, resistant 
to apoptosis and thus active proliferating, characterized by the presence of nuclear β-
catenin (Chakrabarty, et al. 2003; Chakrabarty et al. 2005).  
In colon adenocarcinoma cells the increased extracellular calcium concentration, due to 
the diet, results in the stimulation of proliferation, while the same concentration of 
extracellular calcium has a proapoptotic effect on the neighboring healthy cells. 
Therefore the increase of calcium in the diet has a chemopreventive effect, as 
suggested by several studies in healthy intestinal cells, whereas in cells of 
adenomatous crypts have the opposite effect of being a promoter of carcinogenesis 
(Bostick, et al. 1993; Kleibeuker, et al. 1993). 
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Figure 5. Model for the role of  β-Catenin/TCF in the early stages of intestinal tumorigenesis. 
Modified by van de Wetering et al., Cell (2002). 
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TUMOR CELL LINES AS MODELS OF INTESTINAL EPITHELIUM 
It is not possible to stabilize in vitro culture cells from biopsies of normal human 
intestine, adult or fetal, showing the structural and functional properties of intestinal 
epithelial physiology, so human tumor cell lines are commercially available and 
commonly used as models of intestinal epithelium.  
The established cell lines from explants of human colon carcinomas have represented 
and still represent an important advantage both in experimental, to understand the 
mechanisms intervening in the development of malignant disease of that tissue, and 
for the study of the major biological processes that occur in the intestinal mucosa. 
Tumors of the colon, unlike those of the small intestine, are quite common and have 
provided considerable theoretical and practical knowledge useful for the preparation 
of stable cell lines used as in vitro model of this tissue. Among these, the HT-29 and 
Caco2 cell lines represent the most studied and used experimentally as they have the 
ability, if properly differentiated, to display the typical characteristics of a mature 
enterocitic phenotype (Quaroni and Hochman 1996). 
HT-29 cell line 
This line was established in culture from a human colon adenocarcinoma in 1964 by 
Jørgen Fogh. 
The HT-29 cells when appropriately differentiated provide a good and faithful model 
of polarized intestinal epithelium, which has the function to generate concentration 
gradients of nutrients and electrolytes between the interior and exterior of the cell. This 
polarity reflects the morphology and protein composition of two different asymmetric 
surfaces:  
-a baso-lateral portion, characterized by the presence of protein complexes suitable for 
carrying substances, such as the electrogenic pump Na+-K+/ATPase. The cells of this 
region express antigens of the major histocompatibility complex (MHC class I and II); 
synthesize receptors for dimeric IgA; express functional receptors for peptide and 
hormones.  
-an apical portion which presents the typical structure of the brush border associated 
with the microvilli, whose membrane secretes several hydrolytic enzymes such as 
disaccharidases, alkaline phosphatase, peptidase, all involved in terminal digestion of 
carbohydrates in the diet. Is also able to synthesize molecules with transport function 
for amino acids and sugars. 
The differentiated HT-29 cells are considered to be a heteregeneous cell population 
comprised by mucus-secreting cells, similar to goblet cells, and by entero-endocrine 
cells. At morphological level, as well as brush border, also develop a typical junctional 
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apparatus, consisting of tight junctions, adherent junctions and desmosoms, indicating 
a high degree of differentiation. All these morphological and functional characteristics 
become evident when the cell line HT-29 is induced, in culture, to differentiate. 
Normally these cells grown in vitro under standard conditions do not show features of 
enterocytes, but the differentiation process can be induced by manipulating the growth 
conditions, for example: i) by replacing glucose with galactose (Pinto M 1983), ii) by 
subcultures in the Roswell Park Memorial Institute (RPMI) medium at low glucose (2 
g/L)(Cosentino, et al. 2010, Polak-Charcon, et al. 1989; Zweibaum, et al. 1985). For these 
features, the HT-29 cells are considered a pluripotent enterocitic cell line, able to 
express significant degrees of differentiation depending on culture conditions to which 
cells are subjected (Zweibaum A 1991). 
The HT-29 cells grown in DMEM, high glucose medium (4.5g/L) show an 
undifferentiated phenotype. They form a multistratified epithelium of unpolarized 
cells, that have in the apical portion poorly developed microvilli and no junctional 
apparatus (Cosentino et al. 2010; Polak-Charcon et al. 1989). The enzyme activity, 
although at a limited extent, is still present (Pinto M 1983; Zweibaum A 1991).Within 
the parental population, when maintained in this standard culture conditions, there is 
a small percentage of cells (about 4%) that spontaneously undergoes to differentiation 
along both the enterocytic and mucous secerning goblet lineages (Lesuffleur, et al. 
1990). These observations confirms the pluripotentiality of this cell line (Huet, et al. 
1987). 
Four different cytotypes reside within the mucosa of the intestine: the enterocyte, the 
goblet mucous secerning cell, the enteroendocrine cell and the Paneth's cell (Huet et al. 
1987). 
Caco2 cell line  
The Caco2 cells have been demonstrated to be particularly useful as enterocytic model. 
This line represents a model with notably growth-related differentiation potential 
along the enterocytic lineage since it is able to spontaneously reach an elevated degree 
of maturity when maintained in a post-confluence status, in standard culture 
conditions (Pinto M 1983; Simon-Assmann, et al. 2007), although this methodology 
does not fully reflect the characteristics of physiological epithelium, subjected by a fast 
cell turn over. 
Like the HT-29 cells, this cell line derived from a human colon adenocarcinoma. A 
limiting factor of the maintenance of culture at post-confluence is not fully reflect the 
characteristics of physiological epithelium. 
The enterocytic differentiation is determined by a series of steps with precise 
chronological, morphological an functional characteristics. Moreover this process is 
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strikingly related to the cell proliferation, since it takes place at the post-confluent 
status, a condition in which the proliferation gradually decreases. 
Ferraretto and colleagues established a new original methodological approach to 
induce a differentiated phenotype in these cells. The cell growth conditions were 
carefully standardized so as to provide good reproducibility and a routine procedure 
that allowed a high degree of cell differentiation to be reached without reaching the 
long-term post-confluence status (Ferraretto, et al. 2007). 
When cells reached 100% confluence, as checked by phase-contrast microscopy 
(Olympus, IX50, Tokyo, Japan), they were trypsinized after one day post-confluence 
(Trypsin-EDTA 0.05%-0.02%), diluted (usually 1:3) and then seeded again in a new 
plastic flask. Each trypsinization and successive dilution in a new flask was considered 
as a cell passage.  
The differentiated Caco2 cell shows the typical enterocytic morphology with a 
columnar shape as well as the brush border apparatus with its characteristic 
glycocalyx. The apical microvilli develop in a well-organized structures 
homogeneously distributed on the absorptive surface. In a terminally differentiated 
culture it is possible to observe the dome structures as well as, at the ultrastructural 
level, the complete junctional apparatus, indexes of the formation of a polarized 
epithelium in which the transepithelial transport mechanisms, for ion, water and 
micronutrients, are activated (Ferraretto et al. 2007; Simon-Assmann et al. 2007). 
Functionally the trans-epithelial electrical resistance (TEER) and permeability of 
marker molecules could be used to monitor the integrity of the cell layer (Sambuy, et 
al. 2005). This cell line, in particular, is the model most used in studies of transport of 
xenobiotics and nutrients due to its ability to differentiate into absorbent epithelium. 
Although derived from an adult human colon (where microvillar hydrolases are not 
present), the distinctive characteristic of the Caco2 cells is the ability to synthesize and 
to release a panel of hydrolytic enzymes (sucrase-isomaltase, lactase, aminopeptidases 
and alkaline phosphatase) as marker of enterocytic differentiation typical of the small 
intestinal villus cells (Pinto M 1983; Quaroni and Hochman 1996; Zweibaum A 1991). 
The enzymatic activities are strikingly growth-dependent: different hydrolases are 
expressed and activated at different times along the differentiation process and they 
increase along the post-confluence maintenance (Zweibaum A 1991).  
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CASEIN PHOSPHOPEPTIDES (CPPs):  
BIOACTIVE PEPTIDES DERIVED FROM CASEIN 
About 80% of the bovine milk proteins is represented by the caseins, a family of 
phosphoproteins (αs1-, αs2-, β- and κ-caseins) synthesized by the mammary glandular 
epithelium. In their native state they do not explicate any known biological activity, 
but they constitute a good nutritional source of aminoacids (Schlimme and Meisel 
1995). 
Caseins contain a series of peptides, inactive when hidden within the precursor 
protein, that once released following the gastrointestinal digestive enzymatic 
processes, are able to demonstrate a biological activity (Meisel and Frister 1988; Naito, 
et al. 1972). Among these peptides it is interestingly to point out the opioid receptor 
agonist (casomorphines) and antagonist (cosoxines) peptides, anti-hypertensive 
(casochinines) and anti-thrombotic (casoplatelines) active peptides and 
immunostimulating peptides (immunopeptides) (Meisel and Schlimme 1990; Shah 
2000). 
In addition, among the bioactive peptides, there are also the casein phosphopeptides 
(CPPs), αs1-, αs2-, β-caseins derived phosphorilated peptides, able to bound and 
solubilize minerals, such as calcium, by its serine-associated phosphate groups, 
preventing their precipitation in the calcium-phosphate salt form. This action is 
responsible for the increased bioavailable calcium fraction in the small intestine, and 
particularly at the ileum level (Berrocal, et al. 1989; Erba, et al. 2002; Meisel and 
Olieman 1998). Indeed, the dephosphorilated peptides are not able to bind calcium, 
while the casein phosphorilation increases both its binding capacity and the resistance 
to proteolysis (FitzGerald 1998). 
The high calcium bioavailability of milk and dairy products has been attributed to the 
CPPs formation, along the digestive tract; moreover the high number of 
phosphorilated serine residues, -Ser(P)-, and the consequent high negative charge 
density, account for the resistance of CPPs to further proteolytic digestion and, thus, 
for their accumulation in the distal small intestine, e.g. the ileum (McDonagh and 
FitzGerald 1998). 
Despite of the differences in length and aminoacidic composition, all the CPPs share a 
highly polar ‚acidic domain‛ containing three serine phosphate cluster and glutamyl 
residues: -Ser(P)-Ser(P)-Ser(P)-Glu-Glu-. This sequence is highly conserved between 
the species and represent the binding site for mono and divalent ions, and among them 
the calcium (Kasai, et al. 1992; Schlimme and Meisel 1995; West and Towers 1976). 
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The production of CPPs can be carried out in vitro starting from the bovine sodium 
caseinate, through digestion by pancreatic enzymatic preparations presenting the 
tryptic as the main activity (Sato, et al. 1991).  
Their binding ability varies from 0.4 to 0.6 mg of Ca2+/mg of CPPs, whereas the ion 
solubilizing ability varies from 7.4 to 24 mg of Ca2+/mg of CPPs. There is a net 
distinction between the calcium binding ability and the ability to solubilize it; 
moreover depending on the enzymatic preparation utilized, the calcium solubilizing 
ability changes, probably on the base of the upstream and downstream aminoacidic 
sequence (McDonagh and FitzGerald 1998). 
The calcium binding affinity constant, as determined by capillary electrophoresis, is 
comprised between 102 -103 M-1 (Meisel and Schlimme 1990); this low affinity could 
facilitate the ion release during the intestinal absorption phenomena. 
In the last few years the studies concerning the physico-chemical CPP structure and 
the protein structure-calcium binding correlation have been focused on the two CPPs 
that form in highest amount during the intestinal enzymatic digestion: β-CN(1-25)4P 
and αs1-CN(59-75)5P. The primary sequences of these two peptides are reported in 
Figure 6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Primary structures of the s1-CN (59-79)5P and CN(1-25)4P CPPs purified from 
bovine caseins. The ‚acidic motif ‚ characteristic of all CPPs is indicated in bold characters. S 
means the phosphorylated serine. 
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BIOLOGICAL ACTIVITY OF CPPs 
The first indications about a potential physiological role for CPPs came from the 1950, 
when Mellander demonstrated that the tryptic digestion-derived casein 
phosphopeptides were able to increase the bone calcification level in rachitic children 
without a contemporary vitamin D administration (Mellander and Olsson 1956). 
Subsequently it was demonstrated that their administration induced an increased 
calcium absorption in rats (Patrick and Bacon 1957), and their presence in the diet of 
ovariectomized female rats was able to reduce the bone mineral density loss (Tsuchita, 
et al. 1996). 
The proved ability of CPPs to prevent the precipitation of calcium in the presence of 
phosphate has suggested the possibility that CPPs could enhance the amount of 
soluble calcium in the intestinal lumen, thereby increasing the mineral availability for 
absorption in the small intestine (Kitts and Yuan 1992). Nevertheless, experiments in 
vitro with intestinal preparations and animals (pigs and rats) fed a soy protein rich diet 
implemented with CPPs, however, have provided conflicting results, and especially 
they do not have clarified in any way the molecular mechanism used by these peptides 
to increase absorption of calcium (Pointillart and Gueguen 1989; Sato, et al. 1986).  
On the contrary, in vitro cell studies demonstrated with no doubts that CPPs can affect 
diverse biological function. The first direct evidence of an interaction between 
intestinal cells and CPPs came from the observation that in presence of CPPs and 
extracellular calcium, HT-29 and Caco2 cells, two known human intestinal in vitro cell 
models, are induced to uptake calcium ions from the extracellular milieu (Ferraretto, et 
al. 2001). This activity was subsequently recognized to be due to the presence of a 
structural CPP conformation, conferred by both the phosphorylated ‘acidic motif’ and 
the preceding N-terminal portion, necessary for the interaction with the cell plasma 
membrane (Ferraretto, et al. 2003). Instrumental to this CPP aptitude is the formation 
of stable aggregates with calcium ions (Ferraretto et al. 2003), in fact the cellular 
response, i.e, the increased intracellular calcium concentration, follows a dose-response 
relationship similar to that reported for the formation of aggregates, with a maximum 
at 4 mM extracellular calcium concentration and a CPP dose of 1280 µM, if a purified 
commercial mixture, or 200 µM, if a single purified CPP (Gravaghi, et al. 2007). 
More recent studies have also provided results concerning differences between the 
intestinal cell lines used, HT-29 and Caco2, in their response to CPPs, evidencing that, 
regardless of the slight differences (mostly at the quantitative levels) between the two 
cell lines, the ability of these cells to take up extracellular calcium under CPP 
stimulation is a molecular attitude expressed upon differentiation (Cosentino et al. 
2010). Another demonstration of the interaction between CPPs and intestinal cells can 
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be derived by two works (Kawahara, et al. 2004; Kitts and Nakamura 2006) presenting 
experimental evidences that a particular CPP sequence, commercially available as 
CPP-III, (Meiji Seika, Tokyo, Japan), consisting of about 90% casein phosphopeptides 
such as bovine αs2-casein (1-32) and β-casein (1-28) and enriched in calcium, 
modulates the intestinal immune system by enhancing the mRNA expression of TNF-α 
as well as IL-6 (a cytokine with functions of modulator of cellular differentiation, 
proliferation and apoptosis) in a dose dependent manner. 
The use of primary human osteoblast-like cells, established in culture from trabecular 
bone samples obtained from waste materials during orthopaedic surgery, has revealed 
interesting and new potentialities for CPPs when administered. Analogously to what 
monitored in intestinal in vitro cell lines, CPPs stimulate calcium uptake by primary 
human osteoblast-like cells and induce an increase in the expression and activity of 
alkaline phosphatase (ALP), a marker of human osteoblast differentiation. Moreover, 
the higher fraction of available calcium due to CPPs enhance calcification nodule 
formation by human SaOS-2 in vitro cell culture (Donida, et al. 2009). 
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2.Aim of the study 
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For several years CPPs were studied in order to prove their usage to increase the 
fraction of calcium absorbed in the ileum, where they concentrated (FitzGerald 1998), 
but the difficulties of the both human and animal studies have provided conflicting 
results (Ferraretto and Fiorilli 2010). 
Instead, studies using in vitro cell cultures have revealed new possibilities for CPPs, 
such as the modulation of the intestinal immune system (Otani, et al. 2001) the anti-
proliferative effects on cultured mammalian intestinal cells (Ganjam, et al. 1997), the 
modulation of cell viability in human cells cultures (Hartmann, et al. 2000) 
In this context, also exist the recent discoveries that CPPs can lead to increases 
intracellular calcium in human intestinal cancer cell lines HT-29 and Caco2 but only 
when differentiated (Cosentino et al. 2010) appears interesting for new applications.  
These results can be considered as well as from the point of view of a resurgence of 
calcium absorption, also in virtue of the fact that influx of calcium ions induced by 
certain mitogenic factors may play a role as messengers of cellular events related to the 
control of proliferation, as well cell viability (Munaron, et al. 2004). In fact, abnormal 
cell proliferation is often associated with pathological conditions such as inflammation 
and cancer (Brown and Attardi 2005; Wright, et al. 1994) 
It can therefore hypothesize that the ability of CPP to keep calcium ions in a soluble 
form could be used to abolish the transmembrane calcium gradient, especially in the  
carcinoma of the colon, where the excess of calcium introduced with the diet favors the 
hyperproliferation of the cells and the absence of CaSR (Calcium sensing receptor) 
results in the absence of apoptotic stimuli (Munaron et al. 2004). 
In fact, acting on the extracellular calcium concentration it could be possible to modify 
the proliferative status of tumor cells. If high calcium concentrations promote the 
proliferation of cancer cells, not expressing the CaSR, then the sequestration of this 
quantity should be able to block the replicative pressure. The hypothesis of a possible 
use of CPPs as anticarcinogens in the intestine, therefore, could be an innovative 
approach to block the carcinogenic hyperproliferation of cells, contributing to stop of 
tumor progression.  
Therefore the aim of the present PhD thesis was: 
1- to explore the possible modulation of cell proliferation and apoptosis by CPPs and 
by the CPP-mediated calcium influx in differentiated HT-29 cells, identifying the 
calcium channels involved, mainly such as the L-type calcium channels known to be 
expressed in this cell line (Larsson et al. 1998; Zawadzki, et al. 2008). The same studies 
were carried on in undifferentiated and differentiated HT-29 cells, in order to verify 
the possibility that CPPs, due to their property to complex calcium ions, may behave 
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also as EGTA, the known calcium chelating agents, affecting the extracellular medium 
and influencing cell functions (Barbiero, et al. 1995). 
2- to clarify whether the biological effect of CPPs in Caco2 cell line was also due to the 
modulation of L-type calcium channels, or to an interaction with the TRPV6 channel, 
the main responsible of the transcellular transport of calcium in the intestinal 
epithelium (Peng et al. 1999). 
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In recent years great interest has been directed to bioactive compounds, molecules 
naturally present in foods which can exert physiologically relevant effects at multiple 
levels in the body, such as at cardiovascular, nervous, gastrointestinal and immune 
level (Meisel 2004). The goal of all the studies devoted to discover new bioactive 
molecules in food is to improve human health simply by consuming a ‚normal diet‛ 
which naturally contains a consistent amount of these bioactive molecules, or by using 
them as additives in food. 
Milk and dairy products are known sources of bioactive peptides; the major protein 
group of dairy products is casein. Casein does not display any bioactivity, being a 
reservoir of amino acids for our health, but peptides coming from the in vitro and/or in 
vivo casein digestion can display particular bioactivities. Among these peptides, casein 
phosphopeptides (CPPs) represent a family characterized by the ability to bind and 
solubilise cations, especially calcium (Berrocal et al. 1989). 
The CPP ability in binding calcium and activate the mineral entry into the intestinal 
cells has been observed in several in vitro studies (Ferraretto et al. 2003; Ferraretto et 
al. 2001; Gravaghi et al. 2007). Moreover, in the last years new potentialities for CPPs 
such as the modulation of cell viability, i.e. proliferation and apoptosis, have been 
demonstrated in different human cell cultures (Hartmann et al. 2000; Meisel and 
Gunther 1998).  
This is of great importance when considering that abnormal cell proliferation and 
apoptosis inhibition is often associated to pathological conditions as inflammation and 
tumor (Brown and Attardi 2005). It was also showed that the mechanisms of entry of 
calcium ions into cells have been associated with cell growth in normal and tumor 
tissues (Munaron et al. 2004).  
More recently, it was demonstrated that in HT-29 cells, as well as in a primary human 
colon cancer cell line (AZ-97), the activation of voltage-activated L-type calcium 
channels, which mediate the calcium influx according to the depolarization state of the 
cell, is correlated to apoptosis and their blockade may promote the growth of colon 
cancer cells (Zawadzki et al. 2008). 
There is, in fact, clear evidence that L-type channels are present in enterocytes; this 
channel is present in the apical membrane of rat intestine, its expression results more 
elevated in distal jejunum and proximal ileum, where the calcium absorption is 
conventionally considered to be higher, about 85%, and to occur by the paracellular 
route, while at duodenum, where the active transport occurs, the TRPV6 channel is 
predominant. The two channels, apart for their localization, differ in their operating 
mode: i) Cav1.3 is activated and mediate the calcium transport under depolarizing 
conditions, TRPV6 is activated by hyperpolarization; ii) Cav1.3 is sensitive to the same 
agonist/antagonists for L-type calcium channels here used, while TRPV6 is not 
(Morgan et al. 2003). Also a recent review supports the idea that this two channels 
have a complementary roles in the regulation of intestinal calcium absorption as 
depolarization and repolarization of the apical membrane occur during and between 
digestive periods, respectively (Kellett 2011).  
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Based on this evidence and the role attributed to calcium in the development and / or 
regression of colon cancer (Whitfield et al. 1995), the aim of this study is to explore the 
possibility that the CPP-mediated calcium influx in differentiated HT-29 cells could 
involve the L-type calcium channels known to be expressed in this cell line (Zawadzki 
et al. 2008) and to study the possible correlated modulation of cell proliferation and 
apoptosis.  
All the experiments were done at physiological condition, the calcium concentration 
present in the growing medium, and at calcium overload. The overload of calcium 
used (6 mM) were chosen in order to mimic the situation at intestinal lumen after a 
meal, since it is reported in literature that in this particular condition the extracellular 
calcium concentration can reach values as high as 10 mM (Bronner 2003). Since tumor 
cells grow in 2 mM calcium concentration, while differentiated cells require small 
amounts of calcium ions to survive (Whitfield et al. 1995), (0.4 mM calcium in RPMI 
1640 medium), the experiments with differentiated cells were carried on both at 2 mM 
and 6 mM calcium, in order to compare results with undifferentiated cells and to 
reproduce more than one step in the increasing calcium concentration after a meal. 
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3.1 Materials and  
Methods 1 
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MATERIALS AND REAGENTS 
Cell culture media, L-Glutamine, antibiotic-antimycotic solution, trypsin-EDTA 
solution, Bay-K8644, Nifedipine, Nimodipine and all other reagents, unless otherwise 
specified, were purchased from Sigma (St. Louis, MO, USA). Foetal bovine serum 
(FBS) was from EuroClone Ltd (West Yorkshire, UK). Fura-2 acetoxymethyl ester 
(Fura-2/AM) was from Calbiochem (La Jolla, CA, USA). Bis-(1,3-dibutylbarbituric acid) 
trimethine oxonol, DiBAC4(3) was obtained from Molecular Probes (Eugene, OR, 
USA). 
 
CELL CULTURE 
HT-29 cell line 
Maintenance in culture. The human colon adenocarcinoma-derived HT-29 cell line (BS 
TCL 132) was supplied by Istituto Zooprofilattico Sperimentale di Brescia (Brescia, 
Italy). These cells, after thawing, are routinely growth in DMEM (Dulbecoo’s Modified 
Eagle Medium) culture medium with high D-glucose content (4.5g/L). The cells are 
cultured in 75cm2 plastic flasks (Costar, Concorezzo, Italy) and kept at 37°C in a 5% 
CO2-95% air atmosphere. The DMEM medium is supplemented with 10% heat-
inactivated foetal bovine serum (FBS), 2 mM L-Glutamine, 0.1 mg/L streptomycin, 
1·105U/L penicillin, 0.25 mg/L amphotericin B. Medium was periodically changed. 
When confluent, the cells are detached from the growth substrate through enzymatic 
digestion (Trypsin-EDTA 0.05-0.02%) of the adhesion-mediating proteins and then 
subcultivated. 
Cultivation in RPMI-1640. After detaching by trypsin-EDTA (0.05-0.02%) cells were 
resuspended in RPMI-1640 (Roswell Packard Memorial Institute) growth medium and 
seeded in a new 75 cm2 flask, where they were maintained till the following passage. 
The RPMI-1640 medium has a low D-glucose content (2g/L) and it is supplemented 
with  10% heat-inactivated foetal bovine serum (FBS), 2 mM L-Glutamine, 0.1 mg/L 
streptomycin, 1·105U/L penicillin, 0.25 mg/L amphotericin B. The medium was 
changed twice a week. 
When a confluence status is reached, the cells are detached from the substratum and 
subcultivated for about 20 passages.  
Apart the D-glucose content, the DMEM and RPMI-1640 media differ for inorganic salt 
composition and concentration, aminoacids and vitamins. 
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METHOD OF DIFFERENTIATION OF THE CELL LINE HT-29 
HT-29 CELLS GROWTH IN DMEM MEDIUM 
 
 
100% CONFLUENCY 
 
 
 
TRYPSIN-EDTA (0.05%-0.02%) 
 
 
 
REMOVAL OF DMEM MEDIUM 
 
 
 
SEEDING IN RPMI 1640 MEDIUM 
 
 
 
SUB-CULTURE OF HT-29 RPMI CELLS 
 
 
Figure 1. Schematic diagram of the growth and differentiation of the HT-29 cell line (Cosentino 
et al. 2010). 
 
45 
 
CASEIN PHOSPHOPEPTIDES 
There have been utilized a commercial CPP mixture kindly provided by DMV (DMV 
International, Netherlands). 
This CPP preparation was constituted by a tryptic derivative of the bovine casein and 
is composed by peptides coming from the proteolitic cleavage of s1 and -casein. The 
use of a CPP mixture, as the CPP DMV, was justified by the fact that, as a result of the 
casein enzymatic gastrointestinal digestion, a mixture of different peptides is normally 
formed. 
The commercial preparation present a molecular weight of 2500 Da.  
All the chemical characteristics are reported in Table 1. 
All the experiments were conducted using the solubilised form of the preparation (200 
mg of CPP in 500 µL of double distilled water).  
 
 
 
 
 
 
 
 
 
 
 
Table 1. Chemical composition of the CPP preparation. The reported data was supplied by the 
producer. 
 
 
CPP DMV 
(CE 90 CPP III) 
CPP content 90.5% 
Ca2+ content 0 
P content 3.7% 
NP -1 (molar ratio) 3.7 
Ser P-1(molar ratio) 0.85 
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CYTOPLASMIC CALCIUM CONTENT MISURATION AT SINGLE 
CELL LEVEL 
Video microscopy experiments allowed to evaluate the CPP ability to induce transient 
increases of the [Ca2+]i in HT-29 cells. Cells were seeded onto sterilized 0.13-0.17 thick 
cover glasses (Ø= 24mm) in 35 mm Petri dishes, at the density of 2.6*104 cells/cm2. Two 
days after seeding, sub-confluent cells were processed. 
Following the medium removal, cells were loaded with 2µM FURA-2/AM and 2µM 
Pluronic F-127 (an anionic surfactant that favours the Fura-2/AM dispersion), for 15 
minutes at 37°C in a standard Krebs-Ringer-HEPES buffer (KRH SD) containing in 
mM: 125 NaCl, 5 KCl, 1.2 KH2PO4, 1.2 MgSO4, 25 HEPES, 2 CaCl2, pH 7.4, according to 
the procedure already described (Cosentino et al. 2010; Ferraretto et al. 2001) 
For the analysis it was used a inverted epifluorescent microscope (Nikon, TE 200) 
equipped with a thermostatic perfusion chamber (PDMI-2 TC-202 A, Medical System 
Corporation Harvard Apparatus, Holliston, MA, USA). 
The cover glass was mounted within the thermostatic chamber with 2 mL KRH SD and 
kept at 37°C. The analysis was carried out within a delimited region of the glass 
(cellular field) containing an average of 80 cells, selected by the software. 
The sample was excited with light coming from a Xenon lamp, which wavelengths is 
selected through the connected monochromator. An automatic device alternate 
between the two excitation wavelengths and the excitation light reaches the sample 
through a 40x oil immersion objective with NA= 1.3 (Nikon Corporation, Tokyo, 
Japan). 
The emitted fluorescence (λ= 510nm) was recorded at 1-2 seconds intervals by a 
intensified CCD camera (Extended Isis, Photonic Science, UK). The system recorded 
the emission at 510 nm following excitation at both 340 and 380 nm, it calculated the 
ratio between the two fluorescence intensities and the images of each cell of the field 
were acquired and analysed, previous background value subtraction, using a data 
acquisition and analysis system (High Speed Dynamic Video Imaging Systems – 
Quanticell 700, Applied Imaging). 
The free calcium ions concentration were calculated from the ratio of the emitted 
fluorescence intensity following excitation at 340 and 380 nm, referring to a calibration 
curve obtained using standard solutions of free Fura-2, in presence of EGTA 5 mM 
(that totally chelates calcium), and of complexed Fura-2 in presence of saturating 
concentration of Ca2+ (5mM), applying the Grynkiewicz equation (Grynkiewicz, et al. 
1985).  
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EVALUATION OF THE EFFECTS OF INHIBITORS/ACTIVATORS 
OF THE VOLTAGE OPERATED L-TYPE CALCIUM CHANNELS 
To evaluate if the mechanisms of action of the CPPs was correlated to the activity of 
the L-type voltage operated calcium channels, and thus that the CPP-induced 
intracellular calcium increases were mediated by their activation, cells were pre-
treated with an agonist and two antagonists of these channels, before the CPP 
administration, to evaluate the consequent effects. 
The (±)Bay-K8644, is a L-type Ca2+-channel activator widely used to evaluate the entity 
of the calcium influxes through the L-type channels in various cell lines, and among 
them the HT-29 (Larsson et al. 1998). 
Nimodipine and Nifedipine, two dihydropyridine derivatives, are L-type Ca2+-channel 
antagonists that have been shown to be able to promote an antiproliferative effect in 
epidermal carcinoma-deriving epithelial cells (Larsson et al. 1998). Both antagonists 
were solubilised in DMSO and administered to cells at the concentration of 30 µM to 
HT-29 cells. In fact, HT-29 cells have been demonstrated to express the L-type Ca2+-
channels in the apical membrane. 
The treatments with these compound were carried out to evaluate their effects on the 
CPP-induced intracellular calcium increases, in video microscopy experiments.  
Bay-K8644, previously solubilised in DMSO, was administered to HT-29 RPMI cells at 
400 nM concentration. Both Nimodipine and Nifedipine were solubilised in DMSO 
and administered to differentiated HT-29 cells at 30 µM concentration. In Video-
imaging experiments, it was primarily evaluated the cell responsiveness to CPPs, then 
after a pre-incubation with the agonist or the antagonists, cells were stimulated with a 
second CPP dose. La2Cl3, known to inhibit Ca2+ entry and cause an irreversible decrease 
in [Ca2+]i (Tsunoda, et al. 1990), was administered to cells at 250 µM concentration after 
treatment with CPPs.  
Cells were submitted to the following stimulation schedules: 
1) 1280µM CPP  
2) washes with KRH SD with 2 mM CaCl2 
3) 30 µM Nimodipine or 30 µM Nifedipine or 400nM (±)-Bay-K8644 
4) 1280 µM CPP  
5) 100 µM ATP in the case of absence of response, with the aim to verify the 
viability of the cell populations 
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CELL PROLIFERATION EVALUATION 
Cell Proliferation ELISA, BrdU chemiluminescence  
The effects of different treatments on cell proliferation were evaluated through the 
measurement of the bromodeoxyuridine (BrdU) cell incorporation, a thymidine 
analogous, which incorporates in the nuclear DNA, during the S phase of the cell cycle, 
of actively dividing cells. Confluent cells were detached from the adhesion substrate 
by trypsin-EDTA (0.05% - 0.02%) treatment, and seeded in a black 96 wells plate at the 
density of 1·104 cells/well, in a final volume of 200 µL. After 24 hours the medium was 
changed and the cells were treated for 24 h with either 1280 μM CPP or 500 μM EGTA 
in foetal bovine serum free media, in the presence of 0.4 - 2 - 6 mM CaCl2. The effect of 
400 nM Bay-K8644, 30 μM Nimodipine, 30 μM Nifedipine in the presence of 0.4 mM 
and 2 mM CaCl2 was determined following the same procedure. 
At the end of the incubation, cells were submitted to a 2 h pulse with 
bromodeoxyuridine (BrdU) and BrdU incorporation into DNA was quantified by the 
chemiluminiscent immunoassay (Roche Applied Science, Milan, Italy) following the 
manufacturer’s instructions. The photon emission was measured by a photomultiplier 
(VICTOR2 Wallac 1420 multilabel counter, PerkinElemer). 
 
APOPTOSIS EVALUATION 
Apo-ONE® assay 
The Apo-ONE® assay (Promega, Madison, WI, USA) is a practical tool to measure the 
activities of caspases (Cysteine protease Aspartate) 3 and 7, which are known to act as 
key effectors in the apoptosis of mammalian cells (Vaux and Strasser 1996). The Apo-
ONE® is based on the ability of Caspase -3 and -7 to hydrolyse the artificial substrate Z-
DEVD-R110 [Rhodamine110, bis-(N-CBZ-L-aspartyl-L-glutamyl-L-valyl-L-aspartic 
acid amide)]. The Z-DEVD-R110 is a profluorescente molecule. If pro-apoptotic stimuli 
cause the activation of Caspase -3 and -7, these operate the cleavage of the site of the C-
terminal aspartate residue sequence DEVD (Asp-Glu-Val-Asp) and the removal of the 
substrate peptide DEVD, with gradual release of fluorophore rhodamine 110, which 
emits fluorescence intensity (λex= 499 nm, λem= 521 nm). The intensity of fluorescence 
produced is proportional to the activity of Caspase -3 and -7 of the sample and is 
quantified and compared with the fluorescence emitted by a concentration of standard 
note rhodamine110.  
Cells (1x104 cells/well), plated in a Microtiter plate (96-well, Greinerbio-one, Cellstar, 
Frickenhausen, Germany), were treated for 24 h with either 1280 μM CPP or 500 μM 
EGTA in foetal bovine serum free media, in the presence of 0.4 - 2 - 6 mM CaCl2.  
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At the end of the incubation are added to each well 100 μl of reagent, established by 
the Caspase Substrate and Apo-ONE® Caspase-3/7 Buffer, 1:100 ratio. After a short 
wave (300-500 rpm, 37° C, 30 seconds) the cells are left at room temperature, strictly in 
the dark. The fluorescence emission at 530 nm, with excitation at 485 nm, was 
monitored between 1 h and 7 h by VICTOR2 Wallac 1420 Multilabel Counter (Perkin 
Elmer, Beaconsfield, UK).  
 
Dapi staining 
The DAPI (4-6 diamino-2-phenylindole-) is a dye that selectively forms fluorescent 
complexes with DNA and showing high specificity for regions rich in AT, IC and AU. 
Based on these properties DAPI is an extremely useful tool in the cytochemical 
investigations: when it binds to DNA, absorbs at a wavelength of 340 nm and emits at 
a wavelength of 488 nm, with fluorescence intensity about 20 times greater than the 
dye not complexed to nucleic acids. At a time when the cell membrane of apoptotic 
cells is impaired, greater amount of DAPI penetrates into the cell and promotes the 
increase of staining directly proportional to the concentration of DNA present. The 
different morphology of apoptotic nuclei, due to a different chromatin condensation or 
fragmentation, may affect the identification of stained cells with DAPI. 
Cells (5x104 cells) seeded on glass coverslips were treated for 24 h with either 1280 μM 
CPP or 500 μM EGTA in foetal bovine serum free media, in the presence of 0.4 - 2 - 6 
mM CaCl2. The same procedure was adopted to study the effect of 400 nM Bay-K8644; 
30 μM Nimodipine; 30 μM Nifedipine in the presence of 0.4 mM and 2 mM CaCl2 in 
HT-29 cells. After the incubation, cells were fixed in 70% ethanol for 15 min at –20°C. 
Then they were stained with 0.4 mg/µL 4',6-diamidino-2-phenylindole (DAPI) for 5 
min and the morphology of the nuclei was examined by Olympus microscope BX50 
(Olympus, Tokyo, Japan) at excitation and emission wavelengths of 358 and 460 nm, 
respectively. The results are expressed as percentage of apoptotic nuclei with respect to 
the total nuclei present in each examined cellular fields, for a total of 12 cellular fields 
analyzed for each treatment in a single experiment. 
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MEASUREMENT OF MEMBRANE POTENTIAL 
DiBAC4(3) belongs to a class of anionic slow potential-sensitive dyes (Plasek and Sigler 
1996) and has been shown to respond to membrane depolarization with an increase in 
fluorescence resulting from the increased intracellular concentration and accumulation 
in intracellular lipid-rich compartments (Postma, et al. 1996).  
Differentiated HT-29 cells (2.5x104 cells/well), plated in a Microtiter plate (96-well, 
Greinerbio-one, Cellstar, Frickenhausen, Germany), were loaded with 500 nM 
DiBAC4(3) in KRH solution. After 15 min of incubation at 37°C and 300 rpm in a 
Thermomixer (Eppendorf, Hamburg, Germany), fluorescence was recorded (λex 490 
nm, λem 510 nm), and here reported as ‚before stimulus‛. Then, either 1280 μM CPP 
DMV, or 1 µM Gramicidin, or an hyperpolarizing KRH solution (5 mM KCl, 0 mM 
NaCl) was added and fluorescence immediately recorded and here reported as ‚after 
stimulus‛. 
 
STATISTICAL ANALYSIS 
Statistically significant differences between two mean values were established by the 
Student’s t test, independent two population t test, performed with Origin 6.0 (a P 
value < 0.05 was considered significant). 
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3.2 Results 1 
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CPP EFFECTS ON PROLIFERATION RATE IN 
UNDIFFERENTIATED/DIFFERENTIATED HT-29 CELLS 
In undifferentiated HT-29 cells the proliferation rate both at physiological [Ca2+]o  
(2 mM) in the growth medium and in calcium overload (6 mM) was not affected by the 
cell incubation with CPPs (a dose at which they are demonstrated to exert the maximal 
bio-activity (Cosentino et al. 2010; Gravaghi et al. 2007) or EGTA (Figure 2A).  
In differentiated HT-29 cells the proliferation rate, measured at 0.4 mM [Ca2+]o, which 
represents the physiological calcium concentration in the growth medium, and at 2 
and 6 mM [Ca2+]o, calcium overload conditions, was increased by CPPs above all at 2 
mM [Ca2+]o (p< 0.05). EGTA determined a strong reduction of the proliferation rate at 
0.4 mM [Ca2+]o, an event not observed at 2 mM [Ca2+]o, while at 6 mM [Ca2+]o the 
proliferation rate was reduced by 43% (p< 0.05), (Figure 2B).   
 
Figure 2. Assessment of the proliferation rate using bromodeoxyuridine assay in HT-29 cells 
undifferentiated (A) and differentiated (B), after administration of 1280 µM CPP and 500 µM 
EGTA. Each bar represents the mean ± S.D. of 3 analogous experiments. Symbols indicate a 
statistically different value from control (*p < 0.05, #p< 0.01). 
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CPP EFFECTS ON APOPTOSIS IN UNDIFFERENTIATED/DIFFERENTIATED  
HT-29 CELLS 
In undifferentiated HT-29 cells the apoptotic activity was increased by CPP 
administration both at 2 mM [Ca2+]o (caspase 3/7 activity and apoptotic nuclei staining, 
Figure 3A and 3B), and at 6 mM [Ca2+]o (apoptotic nuclei staining, Figure 3B). The 
administration of EGTA similarly induced an increase in the apoptotic activity both at 
2 and 6mM [Ca2+]o (apoptotic nuclei staining, Figure 6B). The apparent different results 
obtained by mean of the two different apoptotic activity measurements could be due to 
the chronologically different events in the apoptosis, since the activation of caspases 
precedes the nuclear fragmentation and condensation (Vaux and Strasser 1996). 
 
Figure 3. Assessment of apoptosis in undifferentiated HT-29 cells by Apo-One assay (A) and by 
DAPI staining (B) following administration of 1280 µM CPP and 500 µM EGTA. Each bar 
represents the mean ± S.D. of 3 analogous experiments. Symbols indicate a statistically different 
value from control (*p < 0.05, #p< 0.01). 
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The apoptotic activity of differentiated HT-29 cells was increased by EGTA at all the 
[Ca2+]o considered, except at 6 mM [Ca2+]o, when the caspase 3/7 activity decreases, 
while CPP administration was without any effect (Figure 4A and 4B).  
 
Figure 4. Assessment of apoptosis in differentiated HT-29 cells by Apo-One assay (A) and by 
DAPI staining (B) following administration of 1280 µM CPP and 500 µM EGTA. Each bar 
represents the mean ± S.D. of 3 analogous experiments. Symbols indicate a statistically different 
value from control (*p < 0.05, #p< 0.01). 
 
 
Images of Dapi stained nuclei (Figure 5 and 6) before and after CPP and EGTA 
administrations are meaningful to understand these results.  
Undifferentiated tumor HT-29 cells are not sensitive to calcium overload (6 mM), in 
that no differences were observed either in the proliferation rate (see Figure 2A) and in 
apoptosis activity compared to control cells (Figure 5A and 5D), probably because they 
lack part of the molecular machinery necessary to sense the variation in the 
extracellular calcium concentration able to modulate differentiation and apoptosis 
(Whitfield 2009). Differences were observed with the treatment with CPPs or EGTA 
both in standard condition 2 mM, and in calcium overload (6 mM): while the 
proliferation rate does not change (see Figure 2A), apoptosis activity increased (Figure 
5B, 5C, 5E and 5F), probably due to the CPP and EGTA action of binding calcium ions, 
thus subtracting the proliferative stimulus for tumor cells, without the possibility for 
them to differentiate (Whitfield 2009).  
 
 
 
 
 
55 
 
Figure 5. Images of DAPI stained nuclei in undifferentiated HT-29 cells. Photographs of: control 
cells (Panel A), 1280 μM CPP treated cells in presence of 2 mM [Ca2+]o (Panel B), 500 μM EGTA 
treated cells in presence of 2 mM [Ca2+]o (Panel C), control cells in presence of 6 mM [Ca2+]o 
(Panel D), 1280 μM CPP treated cells in presence of 6 mM [Ca2+]o (Panel E), 500 μM EGTA 
treated cells in presence of 6 mM [Ca2+]o (Panel F). Magnification was 40x. 
 
In differentiated HT-29 cells, after the addition of 500 μM EGTA in 0.4 mM [Ca2+]o cell 
nuclei appeared smaller and rounded (Figure 6B), a classical morphological sign of 
apoptosis, compared to control cells (Figure 6A), accordingly to the drastic fall 
observed in their proliferative rate (see Figure 2B). Probably under this experimental 
condition EGTA has subtracted all the calcium necessary to cells for surviving. When 
500 μM EGTA was administered in 2 mM [Ca2+]o the appearance of Dapi stained nuclei 
(Figure 6C) was not different vs control cells, in accordance with a normal proliferative 
rate and a slight increase in the apoptotic activity (see Figure 3). CPPs, though 
displaying a strong ability to bind calcium ions, did not behave as a cytotoxic agent 
neither in 0.4 mM [Ca2+]o (Figure 6D) nor in 2 mM [Ca2+]o (data not shown). At 6 mM 
[Ca2+]o, a condition in which a lot of cells were not viable (Figure 6E), the CPP addition 
reversed the cells to the control condition (Figure 6F), confirming previous 
observations about its role in maintaining calcium ions in a soluble form (Berrocal et al. 
1989), on the contrary of EGTA.  
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Figure 6. Images of DAPI stained nuclei in differentiated HT-29 cells. Photographs of: control 
cells (Panel A), 500 μM EGTA treated cells in presence of 0.4 mM [Ca2+]o (Panel B), 500 μM 
EGTA treated cells in presence of 2 mM [Ca2+]o (Panel C), 1280 μM CPP treated cells in presence 
of 0.4 mM [Ca2+]o (Panel D), control cells in presence of 6 mM [Ca2+]o (Panel E), 1280 μM CPP 
treated cells in presence of 6 mM [Ca2+]o (Panel F). Magnification was 40x. 
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EFFECT OF AGONIST/ANTAGONIST OF VOLTAGE OPERATED L-TYPE 
CALCIUM CHANNELS ON PROLIFERATION RATE AND APOPTOSIS IN 
DIFFERENTIATED HT-29 CELLS 
CPPs are able to induce [Ca2+]i rise only in differentiated intestinal cells (Cosentino et 
al. 2010), thus the hypothesis that the CPP-induced increment in the proliferation rate 
of differentiated HT-29 cells could be associated to the influx of calcium ions activated 
by the same CPPs. It’s known that an influx of calcium through voltage operated L-
type calcium channels have a mitogenic effect (Munaron et al. 2004), therefore 
experiments were performed in differentiated HT-29 cells with the use of agonist and 
antagonists of this channels. The possibility that the activity of these channels could 
affect the cell proliferation rate and apoptosis, as already described in different in vitro 
cell models (Larsson et al. 1998; Yoo, et al. 1997; Yoshida, et al. 2003; Zawadzki et al. 
2008) was studied at 0.4 mM and at 2 mM [Ca2+]o. The cell treatment with the agonist 
Bay-K8644 increased the proliferation rate (Figure 7A). Nimodipine and Nifedipine, 
which act as L-type calcium channel antagonists (Fox and Green 1986; Larsson et al. 
1998), induced a significant reduction in the proliferation rate together with an increase 
in the apoptosis level (Figure 7B).  
 
Figure 7. Effect of agonist and antagonists of L-type Ca2+ channels in differentiated HT-29 cells. 
Proliferation rate (Panel A) and apoptotic activity determined by DAPI staining (Panel B) of: 
control cells (Crt, 100%), cells treated with either 400 nM Bay-K8644, or 30 µM Nifedipine, or 30 
µM Nimodipine in presence of 0.4 mM and 2 mM [Ca2+]o. Each bar represents the mean ± S.D. of 
3 analogous experiments. Symbols indicate a statistically different value from Crt (*p < 0.05, #p< 
0.01). 
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INTERACTION OF CPPs WITH L-TYPE CALCIUM CHANNELS 
Differentiated HT-29 cells were pre-treated with agonist or antagonists of L-type 
calcium channels and [Ca2+]i changes were recorded by computerized video 
microscopy after CPP administration.  
The behaviour of these cells when stimulated with Bay-K8644 in presence of 2 mM 
[Ca2+]o is reported in Figure 8A. The intracellular calcium rises recorded indicates the 
presence of active L-type Ca2+ channels in the cell population here used, according to 
the literature (Ferrante, et al. 1989; Larsson et al. 1998).  
The administration of the same agonist, Bay-K8644, in CPP responsive cells produced a 
higher response to the subsequent CPP administration (Figure 8B), which accounts for 
a 100% increase in the [Ca2+]i and a 50% increase in the percentage of responsive cells 
(Table 2).  
 
Figure 8. Effect of Bay-K8644 on CPP induced calcium rise in differentiated HT-29 cells.  
(A) 400 nM Bay-K8644 was administered in 2mM [Ca2+]o.  
(B) 1280 μM CPP administration, cell washing and restoration of initial conditions (time axis 
break), followed by 400 nM Bay-K8644 and subsequently 1280 μM CPP. Each line in the graph 
refer to a single cell behavior. Each graph is representative of at least 5 analogous experiments.  
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Both antagonists, Nifedipine and Nimodipine, were able to totally or partially reduce 
the CPP-induced calcium rise in HT-29 RPMI cells, as shown in Figure 9A and 9B. The 
percentage of cells which did not responded to CPP administration after Nimodipine 
or Nifedipine treatment was almost the same and accounts for about 36-38%. The 
remaining 64-62% of the cells responded to CPPs but with a marked reduction in the 
percentage of responsive cells (minus 45%) and in the intracellular calcium 
concentration (minus 52%) in the case of Nimodipine (Table 2), while in the case of 
Nifedipine a marked reduction (minus 47%) was observed only in the intracellular 
calcium concentration (Table 2).  
 
Figure 9. Effect of Nifedipine and Nimodipine on CPP induced calcium rise in differentiated 
HT-29 cell.  
(A) 1280 μM CPP administration, cell washing, 30 µM Nifedipine incubation (10 min, time axis 
break), followed by 1280 μM CPP and 1 μM ATP, as a marker of full cellular viability.  
(B) 1280 μM CPP administration, cell washing, 30 µM Nimodipine incubation (10 min, time axis 
break), followed by 1280 μM CPP and 1 μM ATP.  
Each line in the graph refers to a single cell behavior. Each graph is representative of at least 5 
analogous experiments. 
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Table 2. Statistical analysis of the effects on [Ca2+]i produced by CPP administration after cell 
treatment with Bay-K8644, Nimodipine and Nifedipine. The [Ca2+]i  rise was calculated for each 
single cell by subtracting the baseline from the peak value after CPP administration and 
averaging for all the analyzed cells. The percentage of responsive cells was the percentage of 
cells which responded to CPP administration with [Ca2+]i increments equal to or above 20 nM. 
Each value represents the mean ± SD of 4 analogous experiments. Symbols indicate a statistically 
different value between pre and post-agonist/antagonist administration (*p<0.05, #p<0.01). 
 
 
A further demonstration of the involvement of the L-type Ca2+ channels came from the 
use of La2Cl3, an inorganic inhibitor of calcium entry (Tsunoda et al. 1990), which when 
pre-administered to cells abolished the CPP bioactivity (Figure 10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Changes in the intracellular calcium concentration when cells were stimulated with 
1280 μM CPP, washed and incubated with 250 μM La2Cl3 (5 min) and finally treated with 1280 
μM CPP. Each line in the graph refer to a single cell behavior. Each graph is representative of at 
least 5 analogous experiments. 
 
 
 Pre-agonist/antagonist Post-agonist/antagonist 
 % Responsive cells Δ [Ca2+]i nM % Responsive 
cells 
Δ [Ca2+]i nM 
Bay-K8644 67±20.8 65.5±17 100±0.5* 133±22# 
Nimodipine 91±9 92±48 50±12# 44±19 
Nifedipine 61±23 91±40 54±22 48±21 
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CPP EFFECT ON MEMBRANE POTENTIAL OF HT-29 CELLS 
The membrane potential of differentiated HT-29 cells was measured by the use of 
DiBAC4(3), a probe whose fluorescence increases in depolarized conditions and 
decreases during hyperpolarization.  
CPPs increased the fluorescence activity (plus 16%) at the same entity of Gramicidin 
(plus 13%), a known depolarizing agent (Bronner and Landry 1991), while the 
hyperpolarizing KRH solution decreased fluorescence (minus 34%) (Figure 11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Effect of CPP administration on membrane potential in differentiated HT-29 cells. 
Black bars represent fluorescence intensity of cells loaded with 500 nM DiBAC4(3) before the 
additions of stimuli (100%). White bars represent the change in fluorescence intensity 
(percentage vs ‚before stimuli) of control cells (Crt) and cells treated with: CPP (1280 μM), 
Gramicidine (1 µM) and hyperpolarizing KRH (5 mM KCl). Each bar represents the mean ± S.D. 
of 4 analogous experiments.  Statistically different value vs ‚before-stimuli‛ condition (#p< 0.01). 
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3.3 Conclusions 1 
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In the intestinal crypts, the concentration of extracellular calcium can modulate 
proliferation and apoptosis, cellular events related to the maintenance of a 
differentiated phenotype and/or development of a tumor (Whitfield et al. 1995). 
In fact, the intestinal cells survive with concentrations of 0.05-0.1 mM calcium, and 
when an excess of calcium reaches the intestinal lumen, for example after a meal, the 
cell proliferation stops and the expression of a differentiated phenotype, culminating 
in apoptosis, takes place. The molecular mechanisms underlying this transformation 
sees the involvement of two main mechanisms: the Wnt mechanism and the CaSR 
(Whitfield 2009). 
Enterocytes that undergo neoplastic transformation lose their ability to respond to the 
differentiating stimulus represented by a high concentration of extracellular calcium, 
due to decreased or absent expression of CaSR. Then they become resistant to 
apoptosis and are actively proliferating (Chakrabarty et al. 2003; Chakrabarty et al. 
2005). In colon adenocarcinoma cells, increased extracellular calcium concentration 
with the diet results in the stimulation of proliferation, while the same concentration of 
extracellular calcium has a pro-apoptotic effect on surrounding healthy cells. 
Milk and dairy foods are the most bioavailable source of calcium, due to the presence 
of bioactive peptides such as CPPs which keep it in a soluble form. Hence the 
hypothesis that the CPPs, already shown to be able to increase the intracellular 
concentration of calcium in in vitro models of intestinal cells HT-29 and Caco2 
(Cosentino et al. 2010), may also affect cellular processes of proliferation and apoptosis 
in undifferentiated and differentiated HT-29  cells. 
In undifferentiated tumor HT-29 cells CPPs do not alter the proliferation, but increase 
apoptosis, and this result is also obtained by EGTA, a known calcium chelator. 
Probably they act by the same mechanism: they bind the extracellular calcium, 
lowering its concentration, thus exerting  a stimulus in the sense of reducing the 
proliferative rate, but since these cells lack the necessary mechanisms to differentiate 
go into apoptosis (Figure 12). However, the usage of EGTA as anti-proliferative agent 
in tumor regions is inadequate due to its toxicity for the neighbouring differentiated 
cells, while CPPs never display a cytotoxic activity at the concentration here used (see 
DAPI images). 
 
 
 
 
 
 
 
64 
 
Figure 12. In cancer cells the presence of extracellular calcium increased proliferation, promoting 
tumor progression. The chelating action of CPPs against the extracellular calcium induces 
apoptosis, suggesting that these peptides may be considered as probable anticarcinogens. 
 
In contrast in differentiated HT-29 cells CPPs do not affect apoptosis, but increase the 
proliferation with a maximum effect at 2 mM [Ca2+]o. This is in agreement with 
previous studies, which showed that CPPs induce an uptake of calcium ions in 
differentiated HT-29 cells in presence of extracellular calcium ions and with a precise 
dose response relationship (Gravaghi et al. 2007), according to which their ability, due 
to the formation of aggregates with calcium ions, is higher at 2 mM compared to 6 mM 
[Ca2+]o. EGTA reduces the proliferation at physiological [Ca2+]o, this is because it 
subtract the calcium needed by cells to survive, in fact this event does not happen at 
2mM [Ca2+]o, while at 6 mM [Ca2+]o, the effect is added to the toxicity of such a high 
concentration of calcium. EGTA also increases apoptosis of these cells, especially at 
physiological and  at 6 mM [Ca2+]o, and this is in analogy with the reduction of the 
proliferative rate (see the images of DAPI staining). These results indicate a large 
difference between CPPs and EGTA on differentiated intestinal cells because, although 
it is able to bind calcium ions, CPP is not toxic at physiological [Ca2+]o or in the 
presence of an excess of [Ca2+]o. 
Therefore CPPs protect differentiated cells from the toxicity caused by calcium 
overload and promote their proliferation, while induces apoptosis in cancer cells. 
These results revealed a potential role for CCPs as nutraceuticals and/or functional 
foods, a role distinct from that of mineral carriers, but still important. 
In fact, Wright and colleagues say that if the molecules with inhibitory activity to 
apoptosis are considered tumor promoters (Wright et al. 1994), the peptides that show 
a capacity to induce apoptosis may be considered as possible anticarcinogens (Meisel 
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and FitzGerald 2003). Previous studies have demonstrated an anti-proliferative effect 
of the yogurt fraction on cultured mammalian cells Caco2 and IEC-6 (Ganjam et al. 
1997), an inhibition of peripheral blood cell lymphocyte proliferation (Meisel and 
Gunther 1998), an influence on intestinal cell kinetics by casein peptides generated by 
dairy starter cultures (MacDonald, et al. 1994). Taken together, the experimental 
evidences here presented, whenever confirmed in further in vitro models and in vivo, 
could account for an anticancer role of CPPs. 
To understand the mechanisms by which CPPs promote intracellular calcium entry 
and, at the same time, the proliferation in differentiated HT-29 cells experiments were 
conducted in the presence of agonists and antagonists of L-type calcium channels, 
known to exert pro/anti-proliferative effects in various cell cultures in vitro (Larsson et 
al. 1998; Yoo et al. 1997; Yoshida et al. 2003; Zawadzki et al. 2008). Results here 
presented demonstrate an interaction between CPPs and these calcium entry channels 
in differentiated HT-29 cells. 
Besides, we cannot exclude the contribution, and the interaction of CPPs with other 
channels, since the correlation between ion channels and cancer 
prevention/development is a matter of intensive studies as reported (Fraser and Pardo 
2008; Lang, et al. 2005), and in recent years has shown that a given ion channel can 
influence both cell proliferation and apoptosis depending on the properties of the cells. 
Moreover, the activity of a channel may depend on the interplay with other channels. 
The further result that CPPs, interacting with the L-type calcium channels, depolarize 
the membrane of intestinal cells is very impressive if we consider the recent study by 
Morgan and colleagues on the subunit Cav 1.3 of the L-type channels. Moreover, all 
the calcium present in our body comes from the diet and the principal digestion 
products, i.e. glucose, amino acids, and oligopeptides, are all depolarizing nutrients 
(Sharp and Debnam 1994; Ward and Boyd 1980). 
After the ingestion of milk, CPPs is released by casein, the main protein fraction, and 
accumulate in ileum (Meisel and FitzGerald 2003), where they can associate calcium 
ions but can also interact with the other nutrients here present and deriving by the 
milk digestion as glucose from lactose and other peptides. The interaction of the 
different nutrients on calcium absorption constitutes an issue not completely 
understood, despite the recent findings here described (Morgan et al. 2007; Nakkrasae 
et al. 2010), which deserves further studies, but the results here presented underline 
the importance of consider CPPs as molecules for the intestinal health. 
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All the calcium necessary to our body comes from the diet and it is absorbed mainly 
through two ways: the active transcellular route and the passive paracellular route. 
The highly calcium selective channel TRPV6, also designated as calcium transporter-1 
or CaT1, is predominantly expressed in intestinal epithelial cells and has also been 
localized to human colon cancer (Caco2) cells (Fukushima, et al. 2009; Schoeber, et al. 
2007) and regulating transcellular calcium absorption at intestinal level (Cui, et al. 
2009; Taparia, et al. 2006; Wood, et al. 2001). The TRPV6 gene expression is regulated 
by 1,25-Dihydroxycholecalciferol (1,25(OH)2D3) and also by the extracellular calcium 
concentration, increasing at low and decreasing at high calcium ion concentrations, 
according to a saturation kinetic in the order of mM (Ramasamy 2006). However, the 
molecular mechanisms have not yet been identified but seems to exert a protective role 
when the calcium concentration in the intestinal lumen greatly increases reaching 
values above 6 mM, as observed after a calcium rich meal (Bronner 2003; Slepchenko 
and Bronner 2001), an event which could exert negative effects on the involved cells, 
explaining the rapid TRPV6 inactivation (Peng, et al. 2003). 
Calcium deficiency in the diet is an important factor that increases the expression of 
TRPV6 in the duodenal mucosa of mice (Ko, et al. 2009). Short chain fatty acids 
likewise increase expression of TRPV6 and calcium absorption in the rat colorectal 
epithelium as well as in Caco2 cells (Fukushima et al., 2009).  
TRPV6 in the intestinal epithelium also appears to have a bearing on colon cancer 
development. Thus, TRPV6 expression is significantly enhanced in the Citrobacter 
rodentium-induced transmissible murine colonic hyperplasia model (Peleg, et al. 2010). 
Whereas in the normal colon TRPV6 is restricted to the apical membrane of absorptive 
enterocytes, in the hyperplasia model TRPV6 is also distributed to the proliferating 
zone of the colonic crypts, in which it occurs in the basolateral membrane and 
perinuclear area of many epithelial cells (Peleg, et al. 2010). When the animals are fed 
with a calcium-rich diet, the overexpression of TRPV6 in the hyperplasia model is 
reversed. 
Increased levels of colonic TRPV6 are associated with early-stage colon cancer. Thus, 
TRPV6 has been found to be overexpressed in 66% of stage I tumors and in 17% of 
stage II tumors but is barely detectable in stages III and IV tumors (Peleg, et al. 2010). 
These results suggest that aberrant function of TRPV6 is associated with early colon 
carcinogenesis but not with frank malignancy (Peleg, et al. 2010). This inference is 
supported by experiments with the human colon carcinoma cell line Caco2, which 
constitutively express high levels of TRPV6. 
Dairy food contain high amount of calcium in a soluble form and represent a source of 
molecules, distinct from lactose, able to affect the mineral absorption. In this context 
casein phosphopeptides (CPPs), coming from in vivo and/or in vitro bovine casein 
hydrolysis, due to their ability to bind and solubilise calcium ions, were a matter of 
numerous studies devoted to investigate a potential role for them in calcium 
absorption at the intestinal level (Cosentino, et al. 2010a; Cosentino, et al. 2010b; 
McDonagh and FitzGerald 1998). 
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Indeed, previous studies carried on at molecular level have demonstrated that 
differentiated Caco2 cells display a considerable calcium uptake following CPP 
administration, in contrast with the unresponsiveness of the undifferentiated 
counterparts (Cosentino et al. 2010b), besides the fraction of calcium bound to CPPs is 
directly involved in this event (Cosentino et al. 2010a). 
Also the recent finding presented in the previous Theme 1 shown that in HT-29 cell 
lines CPPs modulate cell proliferation and apoptosis through the interaction of  the L-
type calcium channels. 
Hence the aim of this study was to clarify whether the biological effect of CPPs in 
Caco2 cell line was also due to the modulation of L-type calcium channels, or to an 
interaction with the TRPV6 channel, and if this channel, like the L-type calcium 
channels, is involved in the modulation of proliferation and apoptosis. 
The hypothesis of an interaction with a 1,25(OH)2D3-mediated channel like TRPV6 
comes from the results obtained in previous experiments (Cosentino et al. 2010b) 
which showed that in undifferentiated Caco2 cells treated with 1,25(OH)2D3 (and then 
driven to differentiation), the response to CPPs was greater than that of same cells 
differentiated according to the published protocol (Ferraretto, et al. 2007). 
All the experiments of proliferation and apoptosis were done at physiological 
condition, the calcium concentration present in the growing medium, and at calcium 
overload. Moreover the TRPV6 channel was silencing with the RNA interference 
technique in order to verify a possible interaction with CPPs. 
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MATERIALS AND REAGENTS 
Cell culture media, L-Glutamine, antibiotic-antimycotic solution, trypsin-EDTA 
solution and all other reagents, unless otherwise specified, were purchased from Sigma 
(St. Louis, MO, USA). Foetal bovine serum (FBS) was from EuroClone Ltd (West 
Yorkshire, UK). Fura-2 acetoxymethyl ester (Fura-2/AM) was from Calbiochem (La 
Jolla, CA, USA). 
 
CELL CULTURE 
Caco2 cell line 
The human colon adenocarcinoma derived Caco2 cell line (BS TCL 87) was supplied 
by Istituto Zooprofilattico Sperimentale di Brescia (Brescia, Italy).  
Cells are cultured in 75 cm2 plastic flasks (Costar, Concorezzo, Italy) in EMEM 
(Minimum Essential Medium Eagle's) growth medium supplemented with 15% heat-
inactivated foetal bovine serum (FBS), 1 mM sodium-pyruvate, 2 mM L-Glutamine, 0.1 
mg/L streptomycin, 1·105 U/L penicillin, 0.25 mg/L amphotericin B.  
After one day post-confluence cells were trypsinized (Trypsin-EDTA 0.05%-0.02%), 
diluted (usually 1:3) and then seeded again in a new plastic flask. Each trypsinization 
and successive dilution in a new flask was considered as a cell passage. The parental 
cell line from a single flask was cultured for 50 passages following the experimental 
procedure described and represented in a schematic diagram in Figure 1. The medium 
was changed twice a week (Ferraretto et al. 2007).  
Cultures, kept at 37°C in a 5% CO2- 95% air atmosphere, were periodically checked for 
the presence of mycoplasma and were found to be free of contamination. 
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METHOD OF DIFFERENTIATION OF THE CELL LINE CACO2 
 
SEEDING CELLS 
 
 
GROWING CELLS 
 
 
                                                                                                                        Every 2 days 
medium changed 
100% CONFLUENCY 
 
 
1 DAY POST-CONFLUENCY 
 
 
TRYPSIN-EDTA (0.05%-0.02%) 
 
 
 
SUBCULTURE WITH 
APPROPIATE  DILUITION FACTOR 
   
 
Figure 1. Schematic diagram of the standardized Caco2 cell culture methodology used 
(Ferraretto et al. 2007). 
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RNA INTERFERENCE 
RNA interference technique has been used to assess whether the channel TRPV6 was 
involved in the CPP biological effect. Sequences of siRNA for inhibiting expression of 
TRPV6 gene were designed according to (Irnaten, et al. 2008). 
 
Transfection of siRNA by lipofectamine 
The lipofectamine are a class of molecules characterized by a cationic portion that bind 
to nucleic acids and by a lipid portion which facilitates the passage of complex RNA-
lipofectamine through the cell membrane.  
Cells (19x104 cells/well) were plated in 35 mm Petri dish in order to reach a 30% of 
confluency 24 h later. Then they were washed twice with medium without antibiotic 
and incubated in the same medium.  
siRNA were prepared as follows: siRNA and lipofectamine (Invitrogen, Carlsbad, 
California) were separately diluted in medium without antibiotic and FBS and 
incubated for 5 minutes at room temperature. Successively the two mixtures were 
mixed and left at room temperature for 20 minutes in order to allow the formation of 
complex siRNA-Lipofectamine. After the complex formation siRNA-Lipofectamine 
were added in each well. 24 h later the medium with siRNA-Lipofectamine was 
removed and complete medium were added. 48 h the after incubation with siRNA the 
cells were collected for the evaluation of the silencing of gene expression. 
 
GENE EXPRESSION ANALYSIS 
Gene expression of siRNA TRPV6 was evaluated in Caco2 cells.  
Total RNA was isolated and purified from cell lysates using the RNeasy Mini kit 
(Qiagen, Venlo, The Netherlands). During RNA purification, the RNase-Free DNase 
Set (Qiagen) was used for residual genomic DNA digestion and the RNA isolated was 
quantified by RiboGreen® RNA quantitation assay (Invitrogen, Carlsbad, California). 
800 ng of the isolated RNA was reverse-transcribed to cDNA employing the iScript 
cDNA Synthesis Kit (Bio-Rad Laboratories, Hercules, California). 20 ng of total RNA 
was used as template for real-time PCR performed using the iCycler thermal cycler 
(Bio-Rad Laboratories). PCR mixture included 0.2 µM primers, 50 mM KCl, 20 mM 
Tris/HCl, pH 8.4, 0.8 mM dNTPs, 0.7 U iTaq DNA Polymerase, 3 mM MgCl2, and SYBR 
Green (iQ SYBR Green Supermix; Bio-Rad Laboratories) in a final volume of 20 µL. 
The sequences of the forward and reverse primers are shown in Table 1. 
Amplification and real-time data acquisition were performed using the following cycle 
conditions: initial denaturation at 95 °C for 30 s, followed by 45 cycles of 10 s at 95 °C 
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and 30 s at 58 °C. The fold change in expression of the different genes in control and 
treated cells was normalized to the expression of GAPDH gene.  
The specificity of the PCR product was monitored in every PCR assay by the analysis 
of the melting curves. 
 
Primer Sequence Length 
Primer Forward TRPV6 5’ TACCCATGTCCTTTGCACTC 3’ 20 
Primer Reverse TRPV6 5’ CATCAGGTCGCCAAAAATC 3’ 19 
Primer Forward GAPDH 5’ ACGGATTTGGTCGTATTGG 3’ 19 
Primer Reverse GAPDH 5’ CATGGGTGGAATCATATTGG 3’ 20 
 
Table 1. Sequences of primers for amplification of the TRPV6 gene and GAPDH. 
 
Western blot 
Detection of TRPV6 in Caco2 and HT-29 cells was carried out using standard 
immunoblotting protocol and commercially available antibodies. Cells were gently 
washed tree times with cold PBS and then scraped into homogenization buffer 
containing in (mM): 20 Tris-HCl pH 7.6, 250 NaCl, 3 EGTA, 3 EDTA, protease 
inhibitors and 2 dithiothreitol . The crude cell lysate was homogenized, sonicated and 
subsequently centrifuged for 15 min at 14000 rpm. Protein concentration was 
determined with the Bio-Rad Protein Assay (Bio-Rad, UK). Equal amounts of extracted 
total proteins were separated on an 8% SDS-PAGE gels and transferred to PVDF 
membranes using standard semi-dry technique. Membranes were blocked with 5% 
non-fat dry milk in Tris Buffered Saline with Tween-20 (TBS-T) overnight at 4°C in 
presence of rabbit anti-human TRPV6 primary antibody (Santa Cruz Biotechnology, 
USA) used at a dilution of 1:500. After washing, membranes were incubated with 
HRP-rabbit secondary antibody (1:10000; Santa Cruz Biotechnology, USA) for 1 hour. 
Antibody protein complexes were visualized using an enhanced chemiluminescent 
detection kit (Pierce Biotechnology, Inc., IL). Anti-β-actin monoclonal antibody (1: 
20000; Sigma, USA) was used as a loading control. 
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 MEASUREMENT OF INTRACELLULAR FREE CALCIUM 
CONCENTRATION AT SINGLE CELL LEVEL 
As a result of TRPV6 gene silencing,, the effect of CPP administration was evaluated 
by monitoring the cytoplasmic calcium levels in Caco2 cells in presence of 2 mM  
[Ca2+]o.  
Cells were loaded with 2.5 µM Fura-2 AM and 2.5 µM Pluronic F-127 in Krebs Ringer 
Hepes solution (KRH SD) according to the procedure already described (Cosentino et 
al. 2010b; Ferraretto, et al. 2001). 
For the analysis of intracellular free calcium, [Ca2+]i, see the same paragraph in 
Materials and Methods 1. 
 
 
EVALUATION OF CELL PROLIFERATION AND APOPTOSIS  
Undifferentiated and differentiated Caco2 cells were treated for 24 h with either 1280 
μM CPP or 500 μM EGTA in foetal bovine serum free media, in the presence of 2 and 6 
mM CaCl2. The effect of 400 nM Bay-K8644, 30 μM Nimodipine, 30 μM Nifedipine in 
the presence of 2 mM CaCl2 was determined following the same procedure. Cell 
proliferation was evaluated through the measurement of the bromo-deoxyuridine 
(BrdU) cell incorporation. Apoptosis was evaluated through the Apo-ONE® assay and 
Dapi staining. The procedures of the experiments were the same used for HT-29 cells 
and can be found in the appropriate sections in Materials and Methods 1. 
 
 
STATISTICAL ANALYSIS 
To determine statistically significant differences (p value<0.05 or p value<0.01), the 
results presented were analyzed by Student's t-test independent two population t test, 
χ2 test and ANOVA. The program used was SPSS 19 (IBM Inc.). 
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4.2 Results 2 
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EVALUATION OF THE EFFECT OF L-TYPE CALCIUM CHANNEL AGONIST 
BAY-K8644  
When analyzed by computerized video microscopy, only 5% of Caco2 cells showed a 
change in cytosolic calcium concentration in response to treatment with Bay-K 8644 
(Figure 2). 
Therefore it can be concluded that the majority of Caco2 cells is not sensitive to 
treatment with Bay-K 8644. 
This result confirms the previous observations of a lack of expression of genes for L-
type calcium channels and the consequent absence of functional channels in these cells 
(Nakkrasae, et al. 2010). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Changes in cytosolic calcium concentration in Caco2 cells after administration of 800 
nM Bay K-8644. Each line in the graph represents the behavior of individual cells belonging to 
the cellular field analyzed. The figure represents a typical trace representative of at least three 
similar  experiments. 
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EFFECT OF ACTIVATORS/ INHIBITORS OF L-TYPE CALCIUM CHANNELS  ON 
CELL PROLIFERATION 
In the presence of physiological concentrations of extracellular calcium in the medium 
(2 mM), neither the activator Bay-K 8644 (103.8 ± 9.4% vs control) nor the inhibitors 
Nimodipine and Nifedipine (76.2 ± 10% and 92.7 ± 13.6% vs control, respectively), are 
able to affect the proliferation rate of Caco2 cells (Figure 3). 
The absence of active L-type calcium channels, dihydropyridine sensitive, in Caco2 
cells leads to suppose a different interaction between the CPP and the plasma 
membrane in these cells. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Assessment of proliferation using bromodeoxyuridine assay in differentiated Caco2 
cells in presence of activator/ inhibitors of L-type Ca2+ channels in 2mM [Ca2+]o.  
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TRPV6 GENE EXPRESSION AFTER TREATMENT WITH siRNA SCRAMBLE 
AND siRNA TRPV6  
The efficiency of TRPV6 gene silencing was analyzed by evaluating the expression of 
the transcript compared to treatment with siRNA scramble. In differentiated Caco2 
cells the treatment with siRNA TRPV6 reduced the mRNA expression of  
approximately 60% compared to siRNA scramble (Figure 4). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Levels of TRPV6 mRNA expression in differentiated Caco2 cells following treatment 
with siRNA scramble and siRNA TRPV6. 
 
 
The reduction in the intensity of the specific band for the protein TRPV6, between 75 
and 100 kDa, in differentiated Caco2 cells treated with siRNA TRPV6 confirms the 
silencing of the gene coding for the channel TRPV6 confirm the silencing of the gene 
coding for the channel TRPV6 (Figure 5). 
 
 
 
 
 
 
 
 
 
Figure 5. Western blot of differentiated Caco2 cells treated with siRNA scramble and siRNA 
TRPV6. 
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EVALUATION OF INTRACELLULAR CALCIUM CONCENTRATION IN siRNA 
TRPV6 CACO2 CELLS AFTER CPP ADMINISTRATION 
Using computerized video microscopy, the cell responsiveness to CPPs as well as 
cytoplasmic calcium levels, were assessed in siRNA TRPV6 Caco2 cells.  Regarding 
responsiveness, it can be seen that the percentage of cells responsive to the 
administration of CPP in siRNA TRPV6 cells (10.42%) is statistically lower (χ2 test p 
<0.01), compared to control cells (32.80%) and to siRNA scramble cells (23.90%). The 
responsiveness of siRNA scramble cells was not statistically different from that 
observed in the control (χ2 test p <0.01). 
The increase in intracellular calcium concentration does not change significantly 
(ANOVA p <0.05) between control cells and siRNA treated cells (Table 2). 
 
 % Responsive cells Δ [Ca2+]i nM 
Control 32.80 28.67 ± 7.87a 
siRNA scramble 23.90 34.68 ± 11.73a 
siRNA TRPV6 10.42# 27.68 ± 5.69a 
 
Table 2. Analysis of the CPP effect on intracellular calcium concentration as determined by 
computerized videomicroscopy in control cells, siRNA scramble cells and SiRNA TRPV6 cells. 
The statistical significance for cell responsiveness was assessed using the χ2 test (# significantly 
different from control, p <0.01), while the variations in the intracellular calcium concentration 
were analyzed by ANOVA (values in the same column with the same letter are not significantly 
different, p <0.05). 
 
 
 
 
Next figures show the trend of the changes in the cytosolic calcium after CPP 
administration in control cells, in siRNA scramble cells and siRNA TRPV6 cells. 
Experiments were performed using computerized video microscopy. 
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Figure 6. Changes in cytosolic 
calcium in control cells (A), siRNA 
scramble cells (B) and siRNA TRPV6 
cells (C), after administration of 1280 
µM CPPs. Each line represents a 
single cell behavior taken from to the 
chosen cellular field. Each graph is 
representative of at least three 
independent experiments 
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EVALUATION OF INTRACELLULAR CALCIUM CONCENTRATION IN siRNA 
TRPV6 HT-29 CELLS AFTER CPP ADMINISTRATION 
For comparison, also in HT-29 cells was silenced the gene TRPV6 (60% decrease of 
expression similar to that obtained in Caco2 cells), and analyzed the cellular 
responsiveness to CPPs, with a cellular response by 67%, identical to the value 
observed in the control (67%), in agreement with previous studies (Figure 7) 
(Munaron, et al. 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Changes in cytosolic calcium in siRNA TRPV6 HT-29 cells after administration of 1280 
µM CPP. Each line represents a single cell behavior taken from to the chosen cellular field. The 
graph is representative of at least three independent experiments. 
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EFFECT OF CPP ON PROLIFERATION RATE IN 
UNDIFFERENTIATED/DIFFERENTIATED CACO2 CELLS 
In undifferentiated cells, both under physiological conditions and in the calcium 
overload, the administration of CPP did not cause any statistically significant change 
(86.12 ± 11.08% vs. control for 2 mM [Ca2+]o and 72.21 ± 17.07% vs. control for 6 mM 
[Ca2+]o). 
Even EGTA did not cause any statistically significant change (89.32% ± 8:45 vs. control 
for 2 mM [Ca2+]o and 63.53% ± 18:17 vs. control for[Ca2+]o 6 mM) (Figure 8A). 
In differentiated cells, the CPP treatment (100.33 ± 2.08% vs. control for 2 mM [Ca2+]o 
and 88.67% ± 11:59 vs. control for 6 mM [Ca2+]o) and EGTA treatment (96.70 ± 1.50% vs. 
control for 2 mM [Ca2+]o and 81.33 ± 12.86% vs. control for 6 mM [Ca2+]o) do not cause 
any statistically significant changes in proliferative rate, either in physiological or in 
calcium overload (Figure 8B). 
 
Figure 8. Assessment of proliferation using bromodeoxyuridine assay in undifferentiated (A) 
and differentiated (B) Caco2 cells, after administration of 1280 µM CPP or 500 µM EGTA. Each 
bar represents the mean ± S.D. of 3 analogous experiments. 
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EFFECT OF CPP ON APOPTOSIS IN UNDIFFERENTIATED/DIFFERENTIATED 
CACO2 CELLS 
The evaluation of apoptosis by Apo-One assay showed that in undifferentiated cells,  
in the presence of both calcium concentrations, the administration of CPPs led to a 
statistically significant increase in apoptosis (Figure 9). 
These results were also confirmed by DAPI staining (Figure 10A).  
Conversely, in differentiated cells (Figure 8B) CPPs have no effect.  
The EGTA administration induces a statistically significant increase of apoptosis in 
undifferentiated cells at 2 mM [Ca2+]o, and in differentiated cells both at 2 mM [Ca2+]o 
and 6 mM [Ca2+]o. 
 
 [Ca2+]o 2 mM [Ca2+]o 6 mM 
 Undiff. Caco2 
(% vs Crt) 
Diff. Caco2 
(% vs Crt) 
Undiff. Caco2 
(% vs Crt) 
Diff. Caco2 
(% vs Crt) 
CPP 131.67 ± 7.33* 120.06 ± 19.56 163.01 ± 17.20* 116.53 ± 17.93 
EGTA 113.12 ± 9.50 97.33 ± 15.29 93.13 ± 9.34 71.36 ± 7.22 
 
Table 3. Values of apoptosis obtained by Apo-one assay in undifferentiated and differentiated 
Caco2 cells (* significantly different from control, Student- t test, p <0.05). 
 
Figure 9. Assessment of apoptosis by Apo-One assay in Caco2 cells undifferentiated (A) and 
differentiated (B) following administration of 1280 µM CPP and 500 µM EGTA. Each bar 
represents the mean ± S.D. of 3 analogous experiments, (* significantly different from control, 
Student-t test, p <0.05) 
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 [Ca2+]o 2 mM [Ca2+]o 6 mM 
 Undiff. Caco2 
(% vs Crt) 
Diff. Caco2 
(% vs Crt) 
Undiff. Caco2 
(% vs Crt) 
Diff. Caco2 
(% vs Crt) 
CPP 150.91 ± 11.2* 95.33 ± 1.40 143.51 ± 10.82* 93.14 ± 1.85 
EGTA 131.06 ± 13.94* 149.89 ± 2.66* 115.27 ± 24.57 163.50 ± 4.97* 
 
Table 4. Apoptosis rates obtained by DAPI staining in undifferentiated and differentiated Caco2 
cells (* significantly different from control, Student- t test, p <0.05). 
 
 
Figure 10. Evaluation of the apoptosis rate by DAPI staining in undifferentiated (A) and 
differentiated (B) Caco2 cells following administration of 1280 µM CPP or 500 µM EGTA. Each 
bar represents the mean ± S.D. of 3 analogous experiments, (* significantly different from 
control, Student-t test, p <0.05). 
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4.3 Conclusions 2 
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In recent years it has been established that an increase in the consumption of calcium 
and vitamin D is able to prevent the onset of colorectal cancer (van den Brandt and 
Goldbohm 2006).  
The complex mechanisms that regulate the development of a differentiated or a tumor 
phenotype in the colon are closely associated with molecular mechanisms dependent 
on β-catenin and CaSR (Haegebarth and Clevers 2009; MacLeod, et al. 2007; Whitfield 
2009), although it seems that the target of a diet high in calcium is the TRPV6 channel. 
In human colon this channel is associated with early stages of carcinogenesis. 
A high amount of calcium in the diet seems to induce in a healthy intestinal epithelium 
an inhibition of cellular growth and a decreased expression of TRPV6, while vitamin D 
in high doses induces over-expression of TRPV6 leading to tumor promotion, 
effectively neutralizing the effect of a calcium rich diet (van den Brandt and Goldbohm 
2006).  
When other nutrients are considered, the situation becomes more complicated. In fact, 
calcium and vitamin D are contained in milk and dairy products, known to be good 
sources. 
Based on the results found in HT-29 cells, the purpose of this study was to clarify 
whether the biological effect of CPPs in Caco2 cell line was also due to modulation of 
L-type calcium channels, or was due to an interaction with the channel TRPV6, the 
main responsible for the transcellular calcium transport in the intestinal epithelium. In 
fact Caco2 cell line when differentiated represent the most widely used model in 
studies of transport of xenobiotics and nutrients because it is comprised mainly of 
absorptive entherocites. 
In contrast, the HT-29 cell line, when differentiated, retains the characteristics of an 
heterogeneous population and may include, in addition to absorbing cells, mucus 
goblet as well as entero-endocrine cells (Hekmati, et al. 1990). Moreover, the 
assumption of an interaction of CPPs with different molecular structures at the plasma 
membrane of HT-29 cells compared to Caco2, is supported by the different shapes and 
extent of response to the CPPs by the two cell lines (Cosentino et al. 2010b). 
Calcium uptake experiments conducted in differentiated Caco2 cells in the presence of 
a selective agonist of L-type calcium channel, unlike the HT-29 cells, showed 
significant changes in the intracellular calcium concentration in only 5% of total 
analyzed cells. 
This result confirms the lack of expression of genes for L-type calcium channels 
sensitive to dihydropyridines and the consequent absence of functional channels in 
these cells (Nakkrasae et al. 2010; Thongon, et al. 2009). To confirm this result, the 
90 
 
proliferation of differentiated Caco2 cells is not modulated by the same 
agonist/antagonists of L-type calcium-channel. 
The absence of the active L-type calcium channels in Caco2 cells leads to assume a 
different interaction between CPPs and the plasma membrane in these cells. Among 
the various channels present and involved in the influx of calcium into the intestinal 
epithelium, the most important is TRPV6 which is constitutively expressed in Caco2 
cells (Peleg et al. 2010). 
Since there are no agonists or antagonists for this channel, to verify a possible 
interaction with CPP experiments were conducted on cells silenced for the TRPV6 
gene. The 60% reduction of mRNA expression and the absence of specific band in 
Western blot experiment in Caco2 cells treated with siRNA TRPV6 has confirmed the 
silencing of the gene coding for the channel. 
The computerized video microscopy experiments have shown that in siRNA TRPV6 
cells there is a statistically significant decrease in the percentage of responsiveness to 
CPPs.  
Further confirmation of the interaction of CPPs with TRPV6 in Caco2 cells, comes from 
the silencing of the same channel in HT-29 cells. The results show that in these cells the 
responsiveness to CPPs is the same between control and siRNA (67%), indicating that 
in these cells the interaction of CPPs involves other channels, particularly L-type. 
Based on these preliminary results, therefore we can assume the voltage-gated L-type 
calcium channel and TRPV6 as the main channels involved in calcium uptake induced 
by CPPs in HT-29 and Caco2 cells respectively, but certainly not the only channels 
involved.  
The proliferative activity in Caco2 cells does not appear to be influenced by treatment 
with CPPs, while the apoptotic activity is subject to an increase in undifferentiated 
cells and a reduction in differentiated ones in both physiological and overload 
extracellular calcium concentrations. 
These results do suggest that the interaction of CPP with the channel TRPV6 
modulates cell viability in Caco2 cells, similarly to what happens in HT-29 cells with 
the L-type calcium channels. Moreover this result confirms, even in Caco2 cells, the 
ability of CPPs, as calcium ion chelators and activators of the mineral uptake in 
differentiated cells, to influence the cellular mechanisms underlying the development 
and/or regression of the tumor phenotype. 
In addition, experiments are in progress in our laboratory to evaluate the proliferative 
and apoptotic rate of Caco2 cells after the silencing of TRPV6 channel, and the 
biological role exerted by CPPs. 
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Therefore, in vitro, CPPs are able to modulate the absorption of calcium into Caco2 
cells through the transcellular route by interacting with the channel TRPV6. In 
addition to the channel encoded by the gene TRPV6, CPPs may interact with other 
receptors and/or channels in the membrane. One of these receptors may be the CaSR, a 
membrane calcium sensor, which is able to sense changes in [Ca2+]o and coupled them 
to changes in [Ca2+]i (Hoenderop, et al. 2005). In fact, in adult intestinal cells, the 
expression of CaSR regulates the entry of calcium ions and activates a series of 
mechanisms that lead the cell to stop proliferation, to differentiate and finally undergo 
apoptosis. In the case of tumorigenesis, such as polyps and adenomas, there is a de-
regulation of these mechanisms, whereby an increase in extracellular calcium 
concentration leads to higher rates of uncontrolled cell replication, increasing tumor 
size (Whitfield 2009). 
However these in vitro assessments need support and validation in vivo, where the 
modulating action of these peptides may be easily affected even by the physiological 
conditions of the individual (such as the pH of the gastrointestinal tract) as well as by 
the composition of the meal. 
Ion channels are involved in cell homeostasis and their influence in cell behavior is of 
fundamental importance during development and tumor progression. 
Defects in the channels are called channelopathies and are the basis of many diseases, 
it is therefore essential to study the molecular mechanisms by which these channels are 
involved in biological processes, and the interaction with nutrients and/or molecules in 
foods that constitute our diet.  
There is no doubt that CPPs are a key resource, whether considered as potential 
adjuvants in the process of intestinal calcium absorption and as promoters of 
numerous cellular functions through the activation of calcium signaling pathways, 
with all the implications thereof. 
The role of such peptides as "functional foods" or nutraceuticals for the intestinal 
epithelium may therefore represent an important opportunity for the nutraceutical 
industry, which currently represents a growing market (Vergari, et al. 2011). 
 
 
92 
 
4.4 REFERENCES 2 
Bronner F 2003 Mechanisms of intestinal calcium absorption. J Cell Biochem 88 387-393. 
Cosentino S, Donida BM, Marasco E, Del Favero E, Cantù L, Lombardi G, Colombini 
A, Iametti S, Valaperta S, Fiorilli A, et al. 2010a Calcium ions enclosed in casein 
phosphopeptide aggregates are directly involved in the mineral uptake by 
differentiated HT-29 cells. International Dairy Journal 20 770-776. 
Cosentino S, Gravaghi C, Donetti E, Donida BM, Lombardi G, Bedoni M, Fiorilli A, 
Tettamanti G & Ferraretto A 2010b Caseinphosphopeptide-induced calcium uptake 
in human intestinal cell lines HT-29 and Caco2 is correlated to cellular differentiation. 
J Nutr Biochem 21 247-254. 
Cui M, Klopot A, Jiang Y & Fleet JC 2009 The effect of differentiation on 1,25 
dihydroxyvitamin D-mediated gene expression in the enterocyte-like cell line, Caco-
2. J Cell Physiol 218 113-121. 
Ferraretto A, Gravaghi C, Donetti E, Cosentino S, Donida BM, Bedoni M, Lombardi G, 
Fiorilli A & Tettamanti G 2007 New methodological approach to induce a 
differentiation phenotype in Caco-2 cells prior to post-confluence stage. Anticancer 
Res 27 3919-3925. 
Ferraretto A, Signorile A, Gravaghi C, Fiorilli A & Tettamanti G 2001 Casein 
phosphopeptides influence calcium uptake by cultured human intestinal HT-29 
tumor cells. J Nutr 131 1655-1661. 
Fukushima A, Aizaki Y & Sakuma K 2009 Short-chain fatty acids induce intestinal 
transient receptor potential vanilloid type 6 expression in rats and Caco-2 cells. J Nutr 
139 20-25. 
Haegebarth A & Clevers H 2009 Wnt signaling, lgr5, and stem cells in the intestine and 
skin. Am J Pathol 174 715-721. 
Hekmati M, Polak-Charcon S & Ben-Shaul Y 1990 A morphological study of a human 
adenocarcinoma cell line (HT29) differentiating in culture. Similarities to intestinal 
embryonic development. Cell Differ Dev 31 207-218. 
Hoenderop JG, Nilius B & Bindels RJ 2005 Calcium absorption across epithelia. Physiol 
Rev 85 373-422. 
Irnaten M, Blanchard-Gutton N & Harvey BJ 2008 Rapid effects of 17beta-estradiol on 
epithelial TRPV6 Ca2+ channel in human T84 colonic cells. Cell Calcium 44 441-452. 
Ko SH, Lee GS, Vo TT, Jung EM, Choi KC, Cheung KW, Kim JW, Park JG, Oh GT & 
Jeung EB 2009 Dietary calcium and 1,25-dihydroxyvitamin D3 regulate transcription 
of calcium transporter genes in calbindin-D9k knockout mice. J Reprod Dev 55 137-
142. 
93 
 
MacLeod RJ, Hayes M & Pacheco I 2007 Wnt5a secretion stimulated by the 
extracellular calcium-sensing receptor inhibits defective Wnt signaling in colon 
cancer cells. Am J Physiol Gastrointest Liver Physiol 293 G403-411. 
McDonagh D & FitzGerald RJ 1998 Production of Caseinophosphopeptides (CPPs) 
from Sodium Caseinate Using a Range of Commercial Protease Preparations. 
International Dairy Journal 8 39-45. 
Munaron L, Antoniotti S, Fiorio Pla A & Lovisolo D 2004 Blocking Ca2+entry: a way to 
control cell proliferation. Curr Med Chem 11 1533-1543. 
Nakkrasae LI, Thongon N, Thongbunchoo J, Krishnamra N & Charoenphandhu N 
2010 Transepithelial calcium transport in prolactin-exposed intestine-like Caco-2 
monolayer after combinatorial knockdown of TRPV5, TRPV6 and Ca(v)1.3. J Physiol 
Sci 60 9-17. 
Peleg S, Sellin JH, Wang Y, Freeman MR & Umar S 2010 Suppression of aberrant 
transient receptor potential cation channel, subfamily V, member 6 expression in 
hyperproliferative colonic crypts by dietary calcium. Am J Physiol Gastrointest Liver 
Physiol 299 G593-601. 
Peng JB, Brown EM & Hediger MA 2003 Epithelial Ca2+ entry channels: transcellular 
Ca2+ transport and beyond. J Physiol 551 729-740. 
Ramasamy I 2006 Recent advances in physiological calcium homeostasis. Clin Chem 
Lab Med 44 237-273. 
Schoeber JP, Hoenderop JG & Bindels RJ 2007 Concerted action of associated proteins 
in the regulation of TRPV5 and TRPV6. Biochem Soc Trans 35 115-119. 
Slepchenko BM & Bronner F 2001 Modeling of transcellular Ca transport in rat 
duodenum points to coexistence of two mechanisms of apical entry. Am J Physiol Cell 
Physiol 281 C270-281. 
Taparia S, Fleet JC, Peng JB, Wang XD & Wood RJ 2006 1,25-Dihydroxyvitamin D and 
25-hydroxyvitamin D--mediated regulation of TRPV6 (a putative epithelial calcium 
channel) mRNA expression in Caco-2 cells. Eur J Nutr 45 196-204. 
Thongon N, Nakkrasae LI, Thongbunchoo J, Krishnamra N & Charoenphandhu N 
2009 Enhancement of calcium transport in Caco-2 monolayer through PKCzeta-
dependent Cav1.3-mediated transcellular and rectifying paracellular pathways by 
prolactin. Am J Physiol Cell Physiol 296 C1373-1382. 
van den Brandt PA & Goldbohm RA 2006 Nutrition in the prevention of 
gastrointestinal cancer. Best Pract Res Clin Gastroenterol 20 589-603. 
Vergari F, Tibuzzi A & Basile G 2011 An overview of the functional food market: from 
marketing issues and commercial players to future demand from life in space. Adv 
Exp Med Biol 698 308-321. 
94 
 
Whitfield JF 2009 Calcium, calcium-sensing receptor and colon cancer. Cancer Lett 275 
9-16. 
Wood RJ, Tchack L & Taparia S 2001 1,25-Dihydroxyvitamin D3 increases the 
expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell 
line. BMC Physiol 1 11. 
 
 
 
 
 
 
 
 
 
 
 
95 
 
 
 
 
 
 
 
 
 
5. Appendix 
96 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
97 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
98 
 
In: Casein: Production, Uses and Health Effects  
Editor: Anthony M. Ventimiglia and J.M. Birkenhager  
2011 Nova Sciences Publisher, Inc  ISBN 978-1-62100-129-4 
 
PHOSPHOPEPTIDES OF CASEIN: MINERAL CARRIERS AND POTENTIAL 
NUTRACEUTICALS 
Amelia Fiorilli, Silvia Perego and Anita Ferraretto 
Dipartimento di Chimica, Biochimica e Biotecnologie per la Medicina,  
Università degli Studi di Milano, Milano, Italy 
 
 
ABSTRACT 
The gastrointestinal digestion of casein gives rise to a series of peptides displaying 
particular features and biological activity, such as the immunostimulant, ACE 
inhibitory, antihypertensive, opioid agonist/antagonist, antithrombotic and 
antimicrobial peptides. A last group of peptides, named casein phosphopeptides, are 
defined mineral carriers and originate from the proteolytic cleavage of αs1-, αs2- and 
β-casein. These casein phosphopeptides are characterized by the presence of 
phosphate linked to serine residues all over the amino acid sequence but, above all, 
localized in a particular Ser(P)-Ser(P)-Ser(P)-Glu-Glu sequence, known as the ‚acidic 
motif‛. Although casein-derived phosphopeptides (CPPs) correspond to different 
phosphorylated regions of αs1-, αs2- and β-caseins, all CPPs present the ‚acidic motif‛, 
which was highly conserved among species and centuries. The presence of phosphate 
confer them a high negative charge responsible for their further proteolysis and 
undiscussed ability to bind minerals such as calcium, iron and zinc. Numerous studies 
aimed to demonstrate the possibility to use the CPP mineral binding capacity for 
improving the absorption of calcium and iron at intestinal level, as well as for 
enhancing remineralization of tooth enamel. Besides the controversial results obtained 
with calcium transport studies performed using rat intestinal preparations, the use of 
in vitro human intestinal cell models do confirm that CPPs induce calcium uptake in 
differentiated intestinal cells and this action is correlated to their ability to form 
aggregates of defined size with calcium ions. Also in human primary osteoblast like 
cells CPPs increase the intracellular calcium concentration and the in vitro cell 
mineralization. In all these events the calcium bound to CPPs represents the fraction of 
soluble mineral involved in the process. Finally, new and interesting potentialities for 
CPPs come from recent data displaying a modulation of the intestinal immune system 
by triggering cytokine secretion and stimulating IgA production, the release of IL-6 
cytokine in human epithelial intestinal cell lines, the modulation of cell viability, i.e. 
proliferation and apoptosis in different human cell cultures. Taken together these 
findings claimed for a real possibility to use CPPs as functional food, due to their 
presence in dairy products and their physiological formation in vivo, and for 
nutraceuticals, due to possibility to add to mouth rinse solutions, toothpaste and 
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chewing gum, but also to confectionary products (breakfast foods, sweets, cakes, ice-
cream, milk, powdered milk, yogurt, cheese, sport drinks, mayonnaise..) due to their 
good solubility in water, which will allow to use these peptides as an easy-to-
formulate ingredient in food. 
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Abstract 
Intestinal cells are continuously exposed to food whose components are able to 
modulate some of their physiological functions. Among the bioactive food derivatives 
are casein phosphopeptides (CPPs), coming from the in vitro or in vivo casein 
digestion, which display the ability to form aggregates with calcium ions and to 
increase the uptake of the mineral in differentiated intestinal human in vitro HT-29 
and Caco2 cells. The present study aims to determine a possible modulation by CPPs 
of the paracellular and/or transcellular calcium absorption in these two cell lines. The 
paracellular calcium transport was determined by TEER measurements in Caco2 cells 
and by Lucifer Yellow flow in HT-29 cells. The possible modulation of transcellular 
calcium absorption by CPPs was investigated by determining the mRNA expression 
for TRPV6 calcium channel and VDR receptor in 1,25(OH)2D3 pre treated 
undifferentiated/differentiated cells. Results obtained point out that: i) CPPs do not 
affect paracellular calcium absorption; ii) 1,25(OH)2D3 increases the TRPV6 mRNA 
expression in both types of cells; iii) CPPs per se are not able to affect the VDR and 
TRPV6 mRNA expression; iv) TRPV6 calcium channel mRNA expression slightly 
increases in 1,25(OH)2D3 pre treated undifferentiated HT-29 cells and in 
undifferentiated/differentiated Caco2 cells after CPP administration, though this 
increase is not statistically significant. This slight effect of CPPs could be mainly 
ascribed to their ability to bind extracellular calcium, a known modulator of the 
inactivation of the TRPV6 channel. Since proliferation and apoptosis in tumor cells like 
undifferentiated cells are modulated by calcium and the TRPV6 channel seems to be 
involved in the cancer progression, the results here presented are to be considered 
indicative of a possible influence by food factors like CPPs on physiological processes 
in the intestinal tumor cells. 
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Introduction: It is well known that dietary calcium exerts a chemoprotective role on 
normal differentiated intestinal cells, while it behaves as a carcinogenesis promoter on 
aberrant colonocytes and adenomatous crypts. These different functions can be 
achieved through the modulation of proliferation and/or differentiation processes. 
Milk represents the major source of calcium in the diet, due to the high availability of 
the mineral bound to casein and caseinphosphopeptides (CPPs). CPPs, derived by in 
vitro or in vivo casein hydrolysis, are able to induce calcium uptake in human 
intestinal tumor cells differentiated in vitro toward an enterocityc phenotype.     
Objectives: The CPP properties and abilities could be correlated with a possible 
activation of pathways of calcium signalling in intestinal cells either in standard 
growth condition, or in calcium overload as it might occurs following a meal. 
Design: Undifferentiated and differentiated human intestinal cell lines HT-29 and 
Caco2, as in vitro cellular models of intestinal epithelium, were assayed for: cell 
proliferation (bromodeoxyuridine incorporation); apoptosis (caspase 3/7 activation, 
DAPI staining); intracellular calcium increases (Video-imaging experiments using 
Fura2). 
Results: In HT-29 cells, CPPs differently affected proliferation rate and apoptosis in 
undifferentiated toward differentiated cells, acting through the modulation of the 
voltage operated L-type calcium channels, known to activate calcium entry into the 
cells under depolarization and to exert a mitogenic effect. In Caco2 cells, CPPs did not 
significantly affect proliferation and apoptosis, moreover they induced calcium 
uptakes mainly through the TRPV6 channel, known as the epithelial channel 
responsible for the calcium absorption at duodenum level.  
Conclusion: Taken together these results demonstrate the ability for CPPs, through the 
binding with calcium ions and the stimulated ingression of these ions in differentiated 
cells, to modulate biological activity strictly related to normal or cancer phenotype, 
thus opening the way for a use of CPPs as nutraceutical/functional food. 
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Milk and dairy products are known sources of bioavailable calcium for its association 
with casein, whose proteolysis produces caseinphosphopeptides (CPPs). CPPs are 
phosphorylated peptides able to bind and solubilise calcium. In human intestinal 
tumor cells differentiated in vitro toward an enterocityc phenotype, they also induce a 
calcium uptake. Moreover, in human in vitro osteoblasts, CPPs favour the 
mineralization of the extracellular matrix. CPPs can differently affect proliferation and 
apoptosis in differentiated and/ or tumor intestinal cells. Due to all these properties, 
CPPs may be considered as potential nutraceutical/functional food. 
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Aims. Calcium introduced with the diet and absorbed in the intestinal lumen in 
addition to the known functions in bone and teeth and the maintenance of plasma 
calcium concentration (calcaemia), is able to modulate biological activities of intestinal 
cells such as proliferation, apoptosis and differentiation, involved in the development 
and /or regression of cancer.  Calcium in milk is associated with casein and casein 
phosphopeptides (CPPs). CPPs, derived by in vitro or in vivo casein hydrolysis, are 
known to bind calcium and induce calcium uptake in human intestinal tumor cells 
differentiated in vitro toward an enterocityc phenotype.  These CPP properties and 
abilities could be correlated with a possible activation of pathways of calcium 
signalling in intestinal cells either in standard growth condition, or in calcium overload 
as it might occurs following a meal.  
Materials and Methods. Undifferentiated and differentiated human intestinal cell line 
HT-29 was used as in vitro cellular model of tumor or physiologic intestinal 
epithelium. Cell proliferation rate was estimated by incorporation of 
bromodeoxyuridine. Cell apoptosis was measured by caspase 3/7 activation and nuclei 
DAPI staining. Intracellular calcium concentration was quantified by Video-imaging 
experiments using Fura2. 
Results. In undifferentiated HT-29 DMEM cells, that partially expresses the CaSR and 
mimics the behavior of tumor cells in their early stages, CPPs increase apoptosis, both 
at physiological calcium concentration and in calcium overload. These results are also 
shared by the calcium chelator EGTA, and are presumably due to the ability in binding 
the extracellular calcium. In differentiated RPMI HT-29 cells, CPPs: i) increase 
proliferation, especially in calcium overload; ii) do not affect apoptosis; iii) protect 
from calcium overload toxicity. On the contrary, EGTA behaves as a cytotoxic agent, 
decreasing proliferation and increasing apoptosis. The CPP effect in differentiated 
RPMI cells is related to their ability of activating cell calcium entry, through the 
interaction with the voltage operated L-type calcium channels, known to activate 
calcium entry into the cells under depolarization and to exert a mitogenic effect. 
Moreover, CPPs displays a depolarizing effect on cell membrane. 
Conclusion. Taken together these results demonstrate the ability for CPPs, through the 
binding with calcium ions and the stimulated ingression of these ions in differentiated 
cells, to modulate biological activity strictly related to normal or cancer phenotype 
thus opening the way for a use of CPPs as nutraceutical/functional food. 
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Premesse. Il calcio introdotto con la dieta e presente nel lume intestinale oltre ad essere 
assorbito e concorrere alla stabilizzazione della calcemia è in grado di modulare 
attività biologiche delle cellule intestinali come proliferazione, apoptosi e 
differenziamento, coinvolte nello sviluppo e/o regressione di patologie quali tumore, 
infiammazione cronica e malattie autoimmuni. La trasduzione del segnale 
dall’ambiente extracellulare all’interno delle cellule è operata dal Calcium sensing 
receptor (CaSR), recettore accoppiato a G-proteine, in grado di sentire variazioni della 
concentrazione di calcio extracellulare e di attivare una complessa via di segnalazione. 
La forma attiva della vitamina D, l’1,25(OH)2D3, regola l’espressione del CaSR e del 
canale epiteliale TRPV6 coinvolto nel trasporto transcellulare del calcio, tramite il 
legame con il suo recettore nucleare VDR. 
Obiettivo. Il presente studio intende valutare se i caseinofosfopeptidi (CPP), che si 
originano dalla proteolisi della caseina, complessando gli ioni calcio a livello 
extracellulare possano influenzare le attività cellulari modulate dal legame del calcio 
extracellulare con il CaSR.   
Metodi. L’attività proliferativa di cellule Caco2 differenziate in coltura in vitro è stata 
misurata mediante incorporazione di Bromo-deossi-Uridina. L’apoptosi è stata 
monitorata mediante attivazione delle caspasi effettrici 3 e 7. L’espressione genica del 
recettore VDR come pure del canale TRPV6 è stata valutata in cellule Caco2 
indifferenziate e differenziate mediante RT-PCR e quantificata rispetto all’espressone 
del gene reporter GAPDH. I CPP utilizzati sono costituiti da una miscela commerciale 
comprendente peptidi derivanti dall’ alfa e beta caseina bovina. 
Risultati. Il trattamento delle cellule con i CPP o con CPP e 1,25(OH)2D3 non modifica 
l’espressione del recettore VDR. Il trattamento di cellule Caco2 differenziate con l’ 
1,25(OH)2D3 aumenta di circa 10 volte l’espressione del canale TRPV6. L’aggiunta di 
CPP in coltura a cellule differenziate e pretrattate con l’1,25(OH)2D3 aumenta 
significativamente l’espressione del canale TRPV6.  In presenza di concentrazioni 
elevate di calcio extracellulare i CPP  ne annullano  l’attività antiproliferativa e pro-
apoptotica. 
Conclusioni. La capacità legante il calcio dei CPP si traduce a livello intestinale nella 
modulazione di eventi quali proliferazione, apoptosi ed espressione del canale per il 
calcio TRPV6. Questi risultati indicano la possibilità di considerare i CPP come 
nutraceutici a livello intestinale. 
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